ofloxacin has been researched along with rifampin in 352 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (3.41) | 18.7374 |
| 1990's | 88 (25.00) | 18.2507 |
| 2000's | 124 (35.23) | 29.6817 |
| 2010's | 111 (31.53) | 24.3611 |
| 2020's | 17 (4.83) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Cho, SH; Franzblau, SG; Hwang, CH; Pauli, GF; Wan, B; Warit, S | 1 |
| Abbasoglu, U; Aki-Sener, E; Ertan, T; Kaynak, F; Ozkan, S; Temiz-Arpaci, O; Yalcin, I; Yildiz, I | 1 |
| Amblard, M; Bastide, L; Gualtieri, M; Leonetti, JP; Martinez, J; Pugniere, M; Roquet, F; Villain-Guillot, P | 1 |
| Chen, T; Khalil, H; Riffon, R; Wang, R; Wang, Z | 1 |
| Aki, E; Alper-Hayta, S; Arisoy, M; Kaynak, F; Ozkan, S; Temiz-Arpaci, O; Yildiz, I | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Aki, E; Bolelli, K; Ertan, T; Kaynak, F; Ozkan, S; Tekiner-Gulbas, B; Temiz-Arpaci, O; Yalcin, I; Yildiz, I | 1 |
| Long, F; Rouquette-Loughlin, C; Shafer, WM; Yu, EW | 1 |
| Cattoir, V; Nordmann, P; Poirel, L | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Connell, TG; Curtis, N; Ritz, N; Robins-Browne, R; Sievers, A; Tebruegge, M | 1 |
| Banères-Roquet, F; Gualtieri, M; Leonetti, JP; Pugnière, M; Villain-Guillot, P | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Govender, K; Govender, P; Govender, T; Kruger, HG; Maguire, GE; Muthusamy, K; Onajole, OK; Pillay, M; van Helden, PD; Wiid, I | 1 |
| Jeffrey, BM; Rockey, DD; Sandoz, KM; Stamm, WE; Suchland, RJ | 1 |
| Dempsey, S; Jack, C; Miller, CH; Nisa, S; O'Toole, R | 1 |
| Banerjee, D; Bhat, P; Dinakaran, M; Gadhwal, S; Sriram, D; Yogeeswari, P | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Khanna, A; Pareek, PK; Raj, VS; Rattan, A; Saini, KS; Sharma, P; Singh, H; Sood, R; Tarai, B; Upadhyay, DJ | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Hongmanee, P; Kittakoop, P; Mahidol, C; Ruchirawat, S; Senadeera, SP; Sureram, S | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
| Chestnova, RV; Fattakhov, SG; Mingaleev, DN; Reznik, VS; Saifina, LF; Shulaeva, MM; Valijev, RSh; Voloshina, AD | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Alexandrova, L; Andreevskaya, S; Chernousova, L; Chizhov, A; Karpenko, I; Khandazhinskaya, A; Kochetkov, S; Matyugina, E; Smirnova, T | 1 |
| Alexandrova, LA; Andreevskaya, SN; Chernousova, LN; Chizhov, AO; Efremenkova, OV; Karpenko, IL; Kochetkov, SN; Shmalenyuk, ER; Smirnova, TG | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Cai, G; Cho, S; Franzblau, SG; Jaki, BU; Lee, IA; McAlpine, JB; Napolitano, JG; Pauli, GF; Suh, JW; Wang, Y; Yang, SH | 1 |
| Achar, V; Arora, U; Awasthy, D; Bharath, S; Bheemarao, U; Chinnapattu, M; Coulson, M; de Sousa, SM; Ganguly, S; Gaonkar, S; Ghosh, A; Hameed P, S; Hoffner, S; Humnabadkar, V; Kaur, P; Kumar K N, M; Kumar, CN; Madhavapeddi, P; Manjrekar, P; Menasinakai, S; Mukherjee, K; Nandishaiah, R; Narayan, C; Panduga, V; Patil, V; Puttur, J; Raichurkar, A; Ramya, VK; Reddy, J; Rudrapatana, S; Sambandamurthy, VK; Shanbhag, G; Sharma, S; Sharma, U; Shinde, V; Solapure, S; Waterson, D; Werngren, J | 1 |
| Ambady, A; Guptha, S; Hegde, N; Hosagrahara, VP; Humnabadkar, V; Kaur, P; Mahadevaswamy, J; Nagalapur, K; Narayan, A; Panda, M; Raichurkar, A; Ramachandran, S; Ramachandran, V; Rudrapatna, SS; Sambandamurthy, VK; Sharma, S; Shirude, PS | 1 |
| Dufková, I; Hrabálek, A; Karabanovich, G; Klimešová, V; Němeček, J; Pávek, P; Roh, J; Smutný, T; Stolaříková, J; Vávrová, K; Vejsová, M; Vicherek, P | 1 |
| Devi, PB; Jeankumar, VU; Pedgaonkar, GS; Renuka, J; Saxena, S; Sridevi, JP; Sriram, D; Yogeeswari, P | 2 |
| Babu, KS; Chuppala, A; Jeankumar, VU; Reddy, KI; Renuka, J; Sree, KS; Sridevi, JP; Srihari, K; Sriram, D; Yogeeswari, P | 1 |
| Aree, T; Ganihigama, DU; Hongmanee, P; Kittakoop, P; Mahidol, C; Ruchirawat, S; Sangher, S; Sureram, S | 1 |
| Bowornwiriyapan, K; Daengrot, C; Phongpaichit, S; Rukachaisirikul, V; Sakayaroj, J; Tansakul, C; Thongpanchang, T | 1 |
| Renuka, J; Samala, G; Saxena, S; Sridevi, JP; Sriram, D; Yogeeswari, P | 1 |
| Dixit, PP; Thore, SN | 1 |
| Centárová, I; Cole, ST; Čonka, P; Hrabálek, A; Karabanovich, G; Klimešová, V; Mikušová, K; Němeček, J; Pávek, P; Pávková, I; Roh, J; Šarkan, M; Smutný, T; Stolaříková, J; Székely, R; Vávrová, K; Vejsová, M; Vocat, A; Zemanová, J | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bowornwiriyapan, K; Duangjai, A; Muanprasat, C; Phainuphong, P; Phongpaichit, S; Rukachaisirikul, V; Saithong, S; Sakayaroj, J; Srimaroeng, C | 1 |
| Janupally, R; Jeankumar, VU; Reshma, RS; Saxena, S; Sriram, D; Vats, R; Yogeeswari, P | 1 |
| Chaudhari, K; Jain, P; Patel, HM; Surana, S | 1 |
| Carazo, A; Hrabálek, A; Karabanovich, G; Klimešová, V; Konečná, K; Němeček, J; Pávek, P; Pavliš, O; Roh, J; Stolaříková, J; Valášková, L; Vávrová, K | 1 |
| Avalos-Alanís, FG; Carranza-Rosales, P; Guzmán-Delgado, NE; Hernández-Fernández, E; Hernández-Fernández, J; López-Cortina, S; Morales-Vargas, A; Ordóñez, M; Santiago-Mauricio, MG; Velázquez-Moreno, VM | 1 |
| Carazo, A; Hrabálek, A; Karabanovich, G; Klimešová, V; Němeček, J; Pávek, P; Pavliš, O; Roh, J; Stolaříková, J; Sychra, P; Valášková, L; Vávrová, K; Vlčková, H | 1 |
| Cheng, XW; Fan, YL; Feng, LS; Wu, JB; Zhang, FZ | 1 |
| Alluri, KK; Gottapu, S; Reshma, RS; Sriram, D; Suraparaju, R | 1 |
| Gao, YM; Liang, J; Liu, ZY; Qian, L; Tang, YX; Yan, M; Zhang, NN; Zhang, TY | 1 |
| Bishai, WR; Duan, G; Gunosewoyo, H; Liu, LL; Lun, S; Tang, J; Xiao, S; Yang, F; Yu, LF; Zhang, W | 1 |
| Bera, S; Mondal, D | 1 |
| Bekker, OB; Charushin, VN; Danilenko, VN; Ignatenko, NK; Ishmetova, RI; Korotina, AV; Maslov, DA; Rusinov, GL; Shur, KV; Tolshchina, SG; Vatlin, AA | 1 |
| Chen, T; Li, Z; Lyu, Y; Shan, A; Shang, L; Yang, Y; Zhu, J | 1 |
| Dušek, J; Hrabálek, A; Huszár, S; Jand'ourek, O; Karabanovich, G; Klimešová, V; Kočová Vlčková, H; Konečná, K; Konyariková, Z; Korábečný, J; Korduláková, J; Kučera, T; Mikušová, K; Pávek, P; Pávková, I; Pavliš, O; Roh, J; Savková, K; Stolaříková, J; Vávrová, K | 1 |
| Blanco, C; Demay, F; Dhalluin, A; Ermel, G; Georgeault, S; Giard, JC; Gillet, R; Gomes Von Borowski, R; Hanh Le, H; Jean, M; Radigue, R; Thepaut, M; Trautwetter, A; Tresse, C; van de Weghe, P | 1 |
| Alonso-Rodriguez, N; Briffotaux, J; Buchieri, MV; Cimino, M; Coulibaly, S; Dallemagne, P; Gicquel, B; Lecoutey, C; Mornico, D; Ouattara, M; Rochais, C | 1 |
| Dhawan, S; Girase, PS; Karpoormath, R; Kumar, V; Palkar, MB; Shinde, SR | 1 |
| Bishai, WR; Gunosewoyo, H; Liu, LL; Lun, S; Tang, J; Wang, SS; Xiao, S; Yang, F; Yu, LF; Zhang, W | 1 |
| Kwan, SY; Lee, J; Wong, PC; Yew, WW | 1 |
| Grosset, JH; Ji, B; Perani, EG; Petinon, C | 1 |
| Hara, K; Kaku, M; Koga, H; Kohno, S; Maesaki, S | 1 |
| Banerjee, DK; McDermott-Lancaster, RD | 1 |
| Lang, R; Rubinstein, E; Shasha, B | 1 |
| Gunby, P | 1 |
| Alberte, A; Estébanez, MJ; Martínez-Sagarra, JM; Pascual, PP | 1 |
| Chau, PY; Khin, MA; Kwan, SY; Ma, WK; Yew, WW | 1 |
| Tsukamura, M; Yamori, S | 1 |
| Chan, MK; Cheng, IK; Ng, WS | 1 |
| Jidoi, J; Saito, H; Tomioka, H; Yamada, Y | 1 |
| Heap, BJ | 1 |
| Bertrand, A; Janbon, F; Jonquet, O; Reynes, J | 1 |
| Broggio, R; Guerra, L; Xerri, L | 1 |
| Casal, M; González, J; Gutierrez, J; Ruiz, P | 1 |
| Cancet, B; Clave, D; Didier, J; Henry-Ferry, S; Marty, N | 1 |
| Crowle, AJ; Elkins, N; May, MH | 1 |
| Bertrand, A; Despaux, E; Janbon, F; Jonquet, O; Reynes, J | 1 |
| Grosset, JH | 1 |
| Saito, H; Tsukamura, M; Yasuda, Y; Yoshii, S | 1 |
| Bauer, D; Spohr, M; Traub, WH | 1 |
| Baltch, AL; Ritz, W; Smith, RP | 1 |
| Berning, SE; Elliott, AM; Iseman, MD; Peloquin, CA | 1 |
| Klatser, PR; Schepers, P; Schukkink, RA; van der Vliet, GM; van Gemen, B | 1 |
| Carli, P; Carloz, E; Carsuzaa, F; Chagnon, A; De Jaureguiberry, JP; Galzin, M; Marlier, S | 1 |
| Dhople, AM; Ibanez, MA | 2 |
| Kaatz, GW; Kang, SL; McGrath, BJ; Rybak, MJ; Seo, SM | 1 |
| Bryskier, A; Goh, KS; Rastogi, N | 1 |
| Howard, BM; Pinney, RJ; Smith, JT | 1 |
| Frottier, J; Kirstetter, M; Matsiota-Bernard, P; Nauciel, C; Salord, JM; Staïkowsky, F | 1 |
| Akalin, HE; Akova, M; Gür, D; Hayran, M; Unal, S; Uzun, O | 1 |
| Aissa, F; Amamou, M; Bouhaja, B; Slim, L; Thabet, H; Yacoub, M | 1 |
| Akalin, E; Berker, M; Ozcan, OE; Ozgen, T; Tekkök, IH | 1 |
| Argenson, JN; Curvale, G; Drancourt, M; Raoult, D; Stein, A; Zannier, A | 1 |
| Dhople, AM; Gardner, GD; Ibanez, MA | 1 |
| Saito, H; Tomioka, H | 1 |
| Carpinlioğlu, M; Gülmez, I; Karacagil, M; Sümerkan, B; Tatlişen, A | 1 |
| Giron, KP; Gross, ME; Musher, DM; Tharappel, RA; Williams, TW | 1 |
| Bow, EJ; Feld, R; Louie, TJ; Mandell, LA; Palmer, M; Pater, J; Zee, B | 1 |
| Bampenyu, S; Bundit, C; Kampirapap, K; Kuhacharoen, N; Peerapakorn, S; Poomlek, A; Rungruang, S; Sampoonachot, P; Supanwanit, S; Surasondhi, S; Tiasiri, S; Wiriyawipart, S | 2 |
| Dhople, AM; Dimova, V | 1 |
| Grosset, JH; Ji, B; Perani, EG; Petinom, C | 1 |
| van Ogtrop, ML | 1 |
| Palmer, SM; Rybak, MJ | 1 |
| Herbert, D; Kubendiran, G; Mitchison, DA; Paramasivan, CN; Prabhakar, R; Venkatesan, P | 1 |
| Bryskier, A; Devallois, A; Goh, KS; Rastogi, N | 1 |
| Arvieux, C; Avril, JL; Cartier, F; Jacquelinet, C; Michelet, C; Vu, N | 1 |
| Hanberger, H; Nilsson, LE; Svensson, E | 1 |
| Hadiarto, M; Hudoyo, A; Tjandra, YA | 1 |
| Furukawa, T; Komachi, H; Nagai, R; Saito, Y; Takewaki, S; Uchihara, T | 1 |
| Cambau, E; Guillemin, I; Jamet, P; Ji, B; Perani, E | 1 |
| Tanaka, E | 1 |
| Banerjee, DK; McDermott-Lancaster, RD; McKenzie, S | 1 |
| Argenson, JN; Drancourt, M; Groulier, P; Raoult, D; Roiron, R; Stein, A | 1 |
| Arunthathi, S; Jacob, M; Jesudasan, K; Manimozhi, N; Samuel, P; Vijayakumaran, P | 1 |
| Bryskier, A; Capper, T; Klugman, KP | 1 |
| Bamberger, DM; Chern, RP; Dew, M; Herndon, BL; Kim, SC; Marcus, RF; Mitchell, H; Summers, LE; Suvarna, PR | 1 |
| Kumar, D; Srivastava, BS; Srivastava, R; Subramaniam, P | 1 |
| Cartel, JL; Grosset, JH; Mane, I | 1 |
| Ganapati, R; Gandewar, K; Pai, VV; Shroff, HJ | 1 |
| Amiel, C; Baty, V; Canton, P; Garin, H; Hoen, B; Reyrolle, M; Schuhmacher, H | 1 |
| Grosset, JH; Jamet, P; Ji, B; Perani, EG; Sow, S; Traore, I | 1 |
| Padeĭskaia, EN | 1 |
| Chirgwin, K; El Sadr, WM; Hafner, R; Heifets, LB; Klein, O; Kreiswirth, BN; Matts, JP; Musser, JM; Nelson, ET; Perlman, DC; Salomon, N; Telzak, EE | 1 |
| Baltch, AL; Franke, M; Hioe, W; Michelsen, P; Ritz, W; Smith, RP | 1 |
| Tuohy, M; Washington, JA | 1 |
| Lockwood, DN | 1 |
| Matsuoka, M | 1 |
| Cambon-Michot, C; Defives, T; Krzanowska, C; Le Loët, X; Mejjad, O; Vittecoq, O; Voisin, L | 1 |
| Bhattacharya, SN; Jain, S; Kumar, S; Sehgal, VN | 1 |
| Fallgren, C; Ljungh, A; Petersson, AC; Utt, M; Wadström, T | 1 |
| Diderot, V; Grosset, J; Ji, B; Lienhardt, C; Perani, E; Sow, S | 1 |
| Chirgwin, KD; Cohn, DL; el-Sadr, WM; Hafner, R; Heifets, L; Jones, BE; Klein, O; Matts, JP; Medard, F; Mildvan, D; Nelson, ET; Olibrice, M; Perlman, DC; Salomon, N; Telzak, EE | 1 |
| Bulchand, HO; Ganapati, R; Kingsley, S; Pai, VV; Revankar, CR | 1 |
| Ramu, G | 1 |
| Blétry, O; Cassoux, N; Kemali, Z; Le Hoang, P; Le Thi Huong, D; Piette, JC; Wechsler, B | 1 |
| Arra, GS; Arutla, S; Krishna, DR; Prabhakar, CM | 1 |
| Baltch, AL; Franke, MA; Michelsen, PB; Smith, RP | 1 |
| Ji, B | 1 |
| de Jong, JJ; Endtz, HP; IJzermans, JN; van Gelder, T; Weimar, W | 1 |
| Franzblau, S; Grosset, JH | 1 |
| Brunet, S; Martino, R; Muñoz, L; Sierra, J; Subirà, M; Sureda, A | 1 |
| Ganapati, R; Kingsley, S; Pai, VV; Revankar, CR | 1 |
| Bulchand, HO; Ganapati, R; Pai, VV; Revankar, CR | 2 |
| Ganapati, R; Pai, VV; Revankar, CR; Samy, MS | 1 |
| Jahre, JA; Nguyen, MQ; Ying, W | 1 |
| Guglielmelli, E; Ishida, Y; Ozaki, M; Picorini, L | 1 |
| Guglielmelli, E; Ishida, Y; Pecorini, L | 1 |
| Ebenezer, GJ; Job, CK | 1 |
| Diletto, C | 1 |
| Daulako, EC | 1 |
| Tin, K | 1 |
| Grillone, S; Pattyn, S | 2 |
| Donald, PR; Githui, W; Kam, KM; Lam, CW; Mitchison, DA; Odhiambo, J; Paramasivan, CN; Sirgel, FA; Sole, KM; Tam, CM; Umapathy, KC | 1 |
| Kang-Birken, SL | 1 |
| Coleman, EJ; Mandell, GL | 1 |
| Chauhan, DS; Gupta, UD; Katoch, K; Katoch, VM; Natrajan, M; Sharma, RK; Sharma, VD; Singh, D; Singh, HB; Srivastava, K | 1 |
| Bajaksouzian, S; Jacobs, MR; Joloba, ML | 1 |
| Dobie, D; Hastings, M; Mahendra, P; Richardson, G; Tauro, S | 1 |
| Deb, DK; Srivastava, BS; Srivastava, KK; Srivastava, R | 1 |
| Boccoli, G; Cirioni, O; Ghiselli, R; Giacometti, A; Goffi, L; Mocchegiani, F; Riva, A; Saba, V; Scalise, G | 1 |
| Blanc, L; Diletto, C; Levy, L | 1 |
| Gupte, MD | 1 |
| Andrade, AL; Costa, MB; Gillis, TP; Gomes, MK; Krahenbuhl, JL; Maroclo, AL; Martelli, CM; Narahashi, K; Nery, JA; Peninni, S; Rebello, PF; Sacchetim, SC; Salles, AM; Silva, SA; Stefani, MM | 1 |
| Biswas, SK; Hajra, SK; Majumder, V; Saha, B; Saha, K | 1 |
| Ganapati, R; Khopkar, U; Pai, VV; Shinde, A | 1 |
| Cheon, SH; Dietze, R; Ellner, JJ; Hise, AG; Landen, K; Palaci, M; Phillips, M; Ribeiro, FC; Song, HY; Vinhas, S; Wallis, RS | 1 |
| Choi, CH; Kim, HS; Min, YD | 1 |
| Kashiwabara, Y; Matsuoka, M; Namisato, M | 1 |
| Bernard, L; Carlier, RY; Faye, A; Frot-Martin, B; Morand-Blot, V; Vallée, C | 1 |
| Antia, NH; Bulchand, HO; Ganapati, R; Pai, VV; Revenker, CR; Shetty, VP; Wakade, AV | 1 |
| Bowersox, J | 1 |
| Ataç, G; Kapakli, N; Karasulu, L; Kir, A; Ozmen, I; Sevim, T; Tahaoğlu, K; Törün, T | 1 |
| Adrián, F; del Campo, R; García, C; Gómez-Lus, P; Gómez-Lus, R; Rubio, MC; Sánchez, S | 1 |
| Duan, L; Lin, Y; Wu, Q | 1 |
| Reddy, R; Suneetha, S | 1 |
| Hashimoto, K; Kai, M; Kashiwabara, Y; Kimura, H; Kobayashi, K; Maeda, S; Maeda, Y; Matsuoka, M; Nakata, N | 1 |
| Bonnafous, P; Cambau, E; Jarlier, V; Ji, B; Perani, E; Sougakoff, W | 1 |
| Alfandari, S; Beltrand, E; Caillaux, M; Cazaubiel, M; Cordonnier, M; Dubreuil, L; Khazarjian, A; Maulin, L; Mouton, Y; Senneville, E; Valette, M; Yazdanpanah, Y | 1 |
| Hoeppner, V; Marciniuk, D; Peloquin, CA; Reid, J | 1 |
| Cavalcanti Neto, PF; Costa, MB; Gomes, MK; Maceira, JP; Martelli, CM; Narahashi, K; Pignataro, PE; Rebello, PF; Schettini, AP; Scollard, DM; Stefani, MM; Ueda, ES | 1 |
| Cirioni, O; Ghiselli, R; Giacometti, A; Mocchegiani, F; Riva, A; Saba, V; Scalise, G | 1 |
| Carosi, G; Casari, S; Chiodera, A; Moretti, F; Quiros-Roldan, E; Viale, P | 1 |
| Castiñeiras, AA; Della-Latta, P; Herreras, A; Pérez-Pascual, P; Zarranz, JE | 1 |
| Bogadel'nikova, IV; Kunichan, AD; Semenova, OV; Sokolova, GB | 1 |
| Aguilar, R; Auclair, B; Maslow, JN; Mikota, SK; Peloquin, CA | 1 |
| Dailloux, M; Dauendorffer, JN; Laurain, C; Weber, M | 1 |
| Dhople, AM; Namba, K | 1 |
| Chierakul, N; Chindavijak, B; Chulavatnatol, S; Klomsawat, D | 1 |
| Chen, L; Chen, QL; Yin, JJ | 1 |
| Gillis, TP; Krahenbuhl, JL; Martelli, CM; Stefani, MM | 1 |
| Appelbaum, PC; Bozdogan, B; Chaitram, J; Clark, N; Jevitt, L; Killgore, G; McAllister, S; McDougal, LK; O'Hara, CM; Patel, JB; Tenover, FC; Weigel, LM | 1 |
| Boyce, TG; Watson, AM; Wylam, ME | 1 |
| Chen, ZM; Hua, CZ; Li, JP; Shang, SQ; Sun, XF; Yu, XL | 1 |
| Abalos, RM; Balagon, MV; Cellona, RV; Dela Cruz, EC; Fajardo, TT; Tan, EV; Villahermosa, LG; Walsh, DS; Walsh, GP | 1 |
| Dave, S; Jayanthi, S; Nori, AV; Thappa, DM | 1 |
| Arda, B; Gökengin, D; Gürel, O; Tunçel, M; Yaimazhan, T | 1 |
| Karabay, O; Kayas, D; Sahin, I; Sencan, I | 1 |
| Gurumurthy, P; Kumar, AK | 1 |
| Brian, SR; Kimbrough, RC | 1 |
| Maeda, S | 1 |
| García-Tapia, A; Rodríguez, JC; Royo, G; Ruiz, M | 1 |
| Boibieux, A; Chidiac, C; Issartel, B; Petiot, P; Peyramond, D; Rabar, D | 1 |
| Bose, M; Dam, T; Isa, M | 1 |
| Hoeppner, VH; Jones, W; Marciniuk, DD; Ward, HA | 1 |
| Alemany Francés, L; Blázquez Garrido, RM; Espinosa Parra, FJ; Huerta, FH; Ramos Guevara, RM; Sánchez-Nieto, JM; Segovia Hernández, M; Serrano Martínez, JA | 1 |
| Biswas, SK | 1 |
| Arnold, FW; Wojda, B | 1 |
| Hermida Lazcano, I; Sáez Méndez, L; Solera Santos, J | 1 |
| Ben Hassouna, J; Boussen, H; Bouzid, T; Chargui, R; Chebbi, A; Dhiab, T; Gamoudi, A; Hechiche, M; Khomsi, F; Mtaallah, MH; Rahal, K | 1 |
| Almela, M; Jurado, A; Marco, F; Mensa, J; Ortega, M; Soriano, A | 1 |
| Bhusal, Y; Shiohira, CM; Yamane, N | 1 |
| Barsoum, BN; Mossa, HA; Salem, AA | 1 |
| But, AD; Ersoy, Y; Sonmez, E; Tevfik, MR | 1 |
| Järvinen, A; Kauma, H; Koivula, I; Kotilainen, P; Lumio, J; Nikoskelainen, J; Rintala, E; Ruotsalainen, E; Vaara, M; Valtonen, V | 1 |
| Amsbaugh, S; Huiras, E; Wang, NS; Warren, S; Wever, A | 1 |
| Anguita-Alonso, P; Jacofsky, DJ; Osmon, DR; Patel, R; Piper, KE; Rouse, MS | 1 |
| Baum, GL; Daniele, B; Kramer, MR; Lavy, A; Priess, R; Raz, M; Shitrit, AB; Shitrit, D; Shlomi, D | 1 |
| Kamel, AG; Lim, VK; Norazah, A; Rohani, MY | 1 |
| Cammarota, G; Cianci, R; Gasbarrini, GB; Montalto, M; Pandolfi, F | 1 |
| Almela, M; Bori, G; Gallart, X; García, S; Macule, F; Martínez, JA; Mensa, J; Sierra, J; Soriano, A; Suso, S | 1 |
| Berche, P; Beretti, JL; Blanche, S; Canioni, D; Join-Lambert, OF; Kayal, S; Ouache, M | 1 |
| Ariza, J; Cabellos, C; Doménech, A; Garcia, A; Gudiol, F; Murillo, O; Tubau, F | 1 |
| Gidoh, M; Matsuoka, M; Yamazaki, T | 1 |
| Matsuoka, M; Suzuki, Y | 1 |
| Aguilar, L; Barberán, J; Carroquino, G; Giménez, MJ; Martínez, D; Prieto, J; Sánchez, B | 1 |
| Cantón, E; Colombo Gainza, E; Gil Brusola, A; Gobernado, M; Ortiz Estévez, R; Sahuquillo Arce, JM | 1 |
| Demars, R; Guex, E; Lin, J; Potucek, Y; Weinfurter, J | 1 |
| Cappelletty, DM | 1 |
| Cía, M; Martínez, M; Otermin, I; Pereda, A; Rivero, M | 1 |
| Gidoh, M | 1 |
| Landmann, R; Murphy, CK; Rothstein, DM; Trampuz, A; Widmer, AF; Zimmerli, W | 1 |
| Foo, SS; Lye, DC | 1 |
| Otomo, K; Shi, R; Sugawara, I; Zhang, G; Zhang, J | 1 |
| Ishikawa, M; Ozaki, M | 1 |
| Brandt, C; Henke, U; Kaufmann, R; Kramme, S; Lockwood, DN; Ludwig, RJ; Walker, SL; Wichelhaus, TA; Wolter, M | 1 |
| Costa, MB; Gillis, TP; Gomes, MK; Krahenbuhl, JL; Martelli, CM; Narahashi, K; Pereira, GA; Rebello, PF; Sousa, AL; Stefani, MM | 1 |
| DeMars, R; Weinfurter, J | 1 |
| Bao, D; Pulse, ME; Renick, PJ; Truong, TT; Weiss, WJ | 1 |
| Allen, J; Coleman, DJ; Davies, GR; Fourie, B; Kanyok, T; Levin, J; Lienhardt, C; Mitchison, DA; Mthiyane, T; Reddy, C; Rustomjee, R; Sirgel, FA; Sturm, AW | 1 |
| Adolph, E; Aepinus, C; Petzsch, M; Podbielski, A; von Eiff, C | 1 |
| Gyi, MM; Han, TT; Myint, K; Oo, KN; Wai, KT; Yin, NN | 1 |
| Cohen, C; de Gouveia, L; du Plessis, M; Govender, N; Hoffmann, R; Klugman, KP; Meiring, S; Mpembe, R; Quan, V; Schrag, S; Smith, AM; von Gottberg, A; Whitelaw, A; Wolter, N | 1 |
| Reichman, LB | 1 |
| Aguilar, L; Barberán, J; Carroquino, G; Giménez, MJ; Granizo, JJ; Prieto, J | 1 |
| Ariza, J; Cabellos, C; Cabo, J; Euba, G; Gudiol, F; Murillo, O; Pachón, ME; Tubau, F; Verdaguer, R | 1 |
| Bentayeb, H; Canarelli, B; Douadi, Y; Eb, F; El Samad, Y; Havet, E; Lardanchet, JF; Lescure, FX; Mertl, P; Olory, B; Rousseau, F; Schmit, JL | 1 |
| Arenas, R; Asz-Sigall, D; López-García, L; Neme-Yunes, Y; Vega-Memije, ME; Yuen-Palos, R | 1 |
| Baietto, L; D'Avolio, A; De Rosa, FG; Di Perri, G; Garazzino, S; Patanella, S; Sciandra, M; Siccardi, M | 1 |
| Crapis, M; Cristini, F; Furlanut, M; Negri, C; Pavan, F; Pea, F; Scudeller, L; Viale, P; Zamparini, E; Zuiani, C | 1 |
| Fantin, B; Massias, L; Muller-Serieys, C; Saleh Mghir, A | 1 |
| Bai, XQ; Deng, SJ; Li, R; Liang, QF; Luo, SY; Sun, XG; Wang, ZQ | 1 |
| Hamzavi, IH; Mahmoud, BH; Marcus, DV | 1 |
| Ahogo, C; Cisse, M; Ecra, E; Gbery, I; Kacou, E; Kanga, JM; Kassi, K; Kouame, K; Kouassi, A; Yoboue, P | 1 |
| Chen, YH; Eng, HL; Huang, CK; Lai, CH; Lin, HF; Lin, HH; Lin, JN | 1 |
| Chadha, S; Chandrasekar, V; Chauhan, LS; Dave, PV; Dewan, P; Nalini, S; Narayanan, PR; Paramasivan, CN; Parmar, M; Ramachandran, R; Sahu, S; Sanghvi, AS; Wares, F | 1 |
| Almeida, P; Fissette, K; Martin, A; Paasch, F; Palomino, JC; Portaels, F; Varaine, F; Von Groll, A | 1 |
| Ang, C; Bravo, LT; Destura, RV; Gordon, SM; Hall, GS; Mendoza, M; Procop, GW; Shrestha, NK; Tuohy, MJ | 1 |
| Bernardin, G; Cua, E; de Salvador, F; Dellamonica, J; Hyvernat, H; Landraud, L; Risso, K; Roger, PM; Vassallo, M | 1 |
| Disratthakit, A; Doi, N | 1 |
| Agarwal, A; Arora, A; Kumar, S | 1 |
| Abalos, RM; Balagon, MF; Cellona, RV; Gelber, RH; Saunderson, PR | 1 |
| Cai, HL; Chen, YC; Fang, PF; Gao, W; Li, HD; Liu, YP; Tan, QY; Xu, P; Zhang, F; Zhang, WY; Zhu, RH | 1 |
| Hall, JM; Kahn, MA; Moreland, AA; Moschella, SL; Torske, KR | 1 |
| Bessard, D; Dehecq, E; Ducoulombier, V; Houvenagel, E; Luraschi, H; Prudhomme, C | 1 |
| Carreño-Martinez, C; Fafutis-Morris, M; Fukushima, Y; Garcia, IE; Matsuoka, M; Nakajima, C; Suzuki, Y; Vargas-González, A | 1 |
| Bang, ND; Caws, M; Chau, TT; Day, J; Dung, NH; Farrar, J; Heemskerk, D; Merson, L; Olliaro, P; Pouplin, T; Wolbers, M; Yen, NT | 1 |
| Caws, M; Chau, TT; Day, J; Farrar, J; Heemskerk, D; Wolbers, M; Yen, NT | 1 |
| Campbell, PJ; Cowan, LS; Dalton, TL; Hooks, DP; Metchock, B; Morlock, GP; Plikaytis, BB; Posey, JE; Sikes, RD; Starks, AM | 1 |
| Ambrose, PG; Bhavnani, SM; Caws, M; Chau, TT; Dung, NT; Farrar, J; Hammel, JP; Hien, TT; Kulawy, R; Mai, PP; Reynolds, DK; Thwaites, GE; Török, ME; Van Wart, SA | 1 |
| Gey van Pittius, NC; Grobbelaar, M; Hernandez-Pando, R; Jimenez, A; Leon, R; Louw, GE; McEvoy, CR; Murray, M; van Helden, PD; Victor, TC; Warren, RM | 1 |
| Bajwa, AA; Cury, JD; Samuel, V | 1 |
| Arunagiri, K; Kumar, BN; Menaka, K; Narayanan, S; Oommen, PK; Sekar, B | 1 |
| Girdhar, A; Girdhar, BK; Kumar, A | 1 |
| Connolly, C; Friedland, G; Gandhi, N; Moodley, P; Shah, NS; Sturm, AW; Tayob, N; Zetola, N | 1 |
| Hsueh, PR; Huang, YT; Lai, CC; Liao, CH; Tan, CK | 1 |
| Cho, EH; Jeon, CY; Kang, H; Kim, H; Kim, M; Murray, MB; Park, YK | 1 |
| Chen, X; Gilbert, GL; Kong, F; Li, C; Wang, Q; Zhang, J | 1 |
| Boivin, JF; Jerajani, HR; Setia, MS; Shinde, SS | 1 |
| Badri, T; Belghith, I; Benmously, R; Mokhtar, I; Zaiem, A | 1 |
| Ghate, SD; Pai, VV; Shetty, VP; Wakade, AV | 1 |
| Hsu, LY; Kwa, AL; Lee, W; Lim, TP; Sasikala, S; Syahidah, N; Tan, TT; Tan, TY; Teo, J | 1 |
| Hoshino, Y; Ishii, N; Nakanaga, K; Onoe, H; Takeuchi, T; Yotsu, RR | 1 |
| de Rijk, P; Fissette, K; Martin, A; Palomino, JC; Ramos, E | 1 |
| Eisenberg, N; Govender, K; Hartman, TE; Hatfull, GF; Jacobs, WR; Jain, P; Kriakov, J; Larsen, MH; Makume, M; Moodley, P; O'Donnell, MR; Sturm, AW; Thaler, DS | 1 |
| Gachkar, L; Hajilooi, M; Hashemi, SH; Janbakhsh, A; Keramat, F; Mahjub, H; Majzoobi, MM; Mamani, M | 1 |
| González-Martín, J; Martínez, JA; Rey-Jurado, E; Tudó, G | 1 |
| Hassan, G; Kant, S; Parengal, J; Saheer, S | 1 |
| Ceri, H; Gomes, F; Oliveira, R; Teixeira, P | 1 |
| Coudane, J; Garric, X; Guillaume, O; Lavigne, JP; Van Den Berghe, H | 1 |
| Bensalem, M; Bland, S; Bru, JP; Gaillat, J; Garraffo, R; Guillaume, M; Janssen, C | 1 |
| Mehrani, M; Mortaz-Hejri, S; Sadeghipour, P; Yousefi-Nooraie, R | 1 |
| Keren, I; Lewis, K; Mulcahy, LR | 1 |
| Barnard, M; Bosman, M; Coetzee, G; Gey Van Pittius, N; O'Brien, R; Streicher, E; van Helden, P; Warren, R | 1 |
| Lu, J; Pang, Y; Song, Y; Wang, S; Wang, Y; Zhao, Y | 1 |
| André, M; Commandeur, D; Danguy des Déserts, M; Nguyen, BV; Ould-Ahmed, M; Paleiron, N; Ralec, B; Rioualen, S; Rousset, J | 1 |
| Taha, AB | 1 |
| Attia, AM; Bakry, OA | 1 |
| Bergmann, JF; Cambau, E; Evans, J; Hoang-Nguyen, DT; Lloret-Linares, C; Lopes, A; Mouly, S; Raskine, L; Sellier, P | 1 |
| Cunha, Mda G; Lockwood, DN | 1 |
| Avelleira, JC; Campos, AA; Cruz, RC; Cunha, Mda G; Filho, B; Ghuidella, C; Schettini, AP; Ura, S; Viana, Fdos R; Virmond, M | 1 |
| Banavaliker, JN; Behera, D; Bhatnagar, AK; Hanif, M; Kaushik, A; Makkar, N; Pande, JN; Porwal, C; Singh, UB; Singla, R | 1 |
| Ahogo, KC; Aka, BR; Diabaté, A; Gue, I; Kanga, JM; Kouassi, YI; Kourouma, SH; Taieb, A; Traoré, C; Vagamon, B; Yoboue, P | 1 |
| Choe, KH; Chung, GT; Hwang, SC; Jnawali, HN; Kim, H; Lee, YS; Park, YK; Ryoo, S | 1 |
| Chikamatsu, K; Fujita, A; Matsumoto, T; Mitarai, S; Mizuno, K; Ogata, H; Saito, T; Suetake, T; Suzuki, K; Toyota, E | 1 |
| Aboud, C; Algood, H; Boyd, AS; Braun, N; Burke, VE; Drake, WP; Isom, J; Kaminski, N; King, LE; Oswald-Richter, K; Pandit, KV; Richmond, BW; Taylor, T; Yu, C | 1 |
| Chandrasekaran, V; Dewan, P; Hemanth Kumar, AK; Ramachandran, G; Swaminathan, S; Thomas, A | 1 |
| Chen, Y; Li, GL; Liu, HC; Liu, ZG; Sun, Q; Wan, KL; Wu, XC; Xia, Q; Zhao, LL; Zhao, XQ | 1 |
| Mahmoud, I; Saadi, F; Saidane, O; Souayah, A; Zouari, R | 1 |
| Huang, ZK; Li, JM; Li, WT; Luo, Q; Xiong, GL; Xu, XM | 1 |
| Colorado, CL; Guerrero, MI; León, CI; Torres, JF | 1 |
| Alkhovik, OI; Cherednichenko, AG; Dymova, MA; Filipenko, ML; Khrapov, EA; Petrenko, TI | 1 |
| Choi, SB; Jo, KW; Jung, H; Kang, MR; Lee, YS; Shim, TS | 1 |
| Chen, M; Fu, X; Liu, D; Liu, H; Sun, Y; Wang, C; Wang, J; Yu, X; Zhang, F; Zhang, Q; Zhang, Y; Zhou, G | 1 |
| Augustynowicz-Kopeć, E; Bakuła, Z; Bielecki, J; Jagielski, T; Kamiński, M; Napiórkowska, A; Zwolska, Z | 1 |
| Balagaddé, FK; Luthuli, BB; Purdy, GE | 1 |
| Chen, Y; Liu, HC; Liu, ZG; Sun, Q; Wan, KL; Zhao, B; Zhao, LL; Zhao, XQ | 1 |
| Ardizzoni, E; Aspindzelashvili, R; Bastard, M; de Jong, BC; Goginashvili, L; Kotrikadze, T; Mulders, W; Pangtey, H; Rigouts, L; Varaine, F | 1 |
| Deng, YT; Huang, ZK; Li, JM; Luo, Q; Qing, C; Xiong, GL | 1 |
| Chen, ST; Huang, HR; Jiang, GL; Ma, YF; Wang, GR; Yu, X | 1 |
| Cai, X; Deng, Y; Dong, H; Huan, S; Jing, H; Li, J; Li, Q; Li, X; Ou, X; Pang, Y; Su, B; Tan, Y; Xia, H; Zhang, J; Zhang, Z; Zhao, Y | 1 |
| Dixit, P; Jain, A; Jaiswal, I; Singh, M; Singh, P; Singhal, P | 1 |
| Beltrán-Alzate, C; Brennan, P; Cardona-Castro, N; Kimura, M; Li, W; López Díaz, F; Romero-Montoya, M; Sakamuri, R | 1 |
| Araujo, S; Fontes, AB; Goulart, IMB; Goulart, LR; Li, W; Matsuoka, M; Rosa, PS; Scollard, DM; Suffys, P; Truman, RW; Vissa, V; Williams, DL | 1 |
| Boibieux, A; Delaunay, J; Guillem, P; Jullien, D; Tristan, A; Villani, AP | 1 |
| Alene, KA; Bai, L; Clements, ACA; Gray, DJ; McBryde, ES; Viney, K; Xu, Z; Yang, K; Yi, H | 1 |
| Anupurba, S; Balgam, S; Fakir, NA; Gupta, A; Nema, V; Pal, SK; Pandey, D; Periera, M; Rathod, S; Sekar, G; Sinha, D; Sinha, P; SivaKumar, S; UmaDevi, KR | 1 |
| Clifton, DA; Crook, DW; Iqbal, Z; Niehaus, KE; Peto, TEA; Smith, EG; Walker, AS; Walker, TM; Wilson, DJ; Yang, Y; Zhu, T | 1 |
| Boggild, AK; Bonnar, PE; Cunningham, NP; Davis, IRC; Sharma, R; Walsh, NM | 1 |
| Antiabong, JF; Lekalakala, RM; Malinga, LA; Maningi, NE; Mbelle, NM | 1 |
| Cambau, E; Cardona-Castro, N; Cauchoix, B; Cole, ST; Cooreman, EAWD; Gillini, L; Gupta, UD; Hagge, D; Hongseng, W; Indropo, A; Johnson, RC; Kai, M; Lavania, M; Matsuoka, M; Miyamoto, Y; Pannikar, VK; Pemmaraju, VRR; Rosa, PS; Saunderson, P; Srikantam, A; Suffys, P; Vissa, V; Williams, D | 1 |
| Acuña-Villaorduña, A; Barrionuevo, P; De la Cruz-Luque, C; Domecq, JP; Lazo-Porras, M; Málaga, G; Ponce, OJ; Prokop, LJ; Prutsky, GJ; Tapia, JC; Ugarte-Gil, C | 1 |
| Gao, R; Guo, Y; Shen, X; Tan, G; Wang, H; Wu, X; Wu, Z; Yang, J; Yu, F | 1 |
| Jafari, R; Moghim, S; Nasr Esfahani, B; Safari, M; Salehi, M | 1 |
| Ahuja, M; Darlong, J; Kumar, A; Lavania, M; Nathan, R; Pathak, VK; Sengupta, U; Singh, I; Turankar, RP | 1 |
| Ji, Y; Li, Z; Liu, Q; Martinez, L; Qiu, B; Song, H; Wang, J; Yang, D | 1 |
| Ahumada-Topete, VH; Charli-Joseph, Y; Fernández-Sánchez, M; Flores-Suárez, LF; Rodríguez, M | 1 |
| Guo, Y; Liu, H; Sha, W; Shen, H; Shen, X; Tan, G; Wu, X; Wu, Z; Yang, J; Yu, F | 1 |
| Guo, Y; Huang, C; Sha, W; Tan, G; Wu, X; Yang, J; Yu, F | 1 |
| Ahuja, M; Darlong, J; Hembrom, S; Lavania, M; Pathak, VK; Sengupta, U; Singh, I; Singh, SV; Turankar, RP | 1 |
| Bland, MJ; Gabant, P; Gala, JL; Martin, A; Rodriguez-Villalobos, H | 1 |
| Balasubramanium, G; Elangovan, R; Gupta, SS; Lodha, T; Muthulakshmi, T; Perumal, V; Sivaraman, GK; Visnuvinayagam, S; Yadav, A | 1 |
| Jin, G; Li, G; Li, X; Li, Y; Shao, Y; Wei, P; Yang, J; Zhang, L | 1 |
| Ahuja, M; Khurana, A; Muddebihal, A; Sachdeva, S; Sardana, K; Sharma, R; Singh, I | 1 |
| Chhabra, S; Dogra, S; Jain, S; Kaur, M; Minz, RW; Nadeem, M; Narang, T; Pandey, P; Sahu, S; Sharma, A; Sharma, K; Sharma, R; Shilpa, S; Singh, I; Yadav, R | 1 |
13 review(s) available for ofloxacin and rifampin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Mycobacterium Tuberculosis (MTB) GyrB inhibitors: An attractive approach for developing novel drugs against TB.
Topics: Antitubercular Agents; Clinical Trials as Topic; DNA Gyrase; Drug Discovery; Humans; Mycobacterium tuberculosis; Topoisomerase II Inhibitors | 2016 |
Fluoroquinolone derivatives and their anti-tubercular activities.
Topics: Animals; Antitubercular Agents; Dose-Response Relationship, Drug; Fluoroquinolones; Humans; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Tuberculosis | 2018 |
Insights of synthetic analogues of anti-leprosy agents.
Topics: Humans; Leprostatic Agents; Leprosy; Structure-Activity Relationship | 2019 |
An appraisal of anti-mycobacterial activity with structure-activity relationship of piperazine and its analogues: A review.
Topics: Animals; Antitubercular Agents; Drug Design; Drug Discovery; Humans; Mycobacterium tuberculosis; Piperazine; Structure-Activity Relationship; Tuberculosis | 2021 |
Pharmacokinetics in drug screening.
Topics: Animals; Biological Availability; Body Weight; Dapsone; Drug Evaluation, Preclinical; Humans; Leprostatic Agents; Leprosy; Ofloxacin; Oxazines; Rifampin; Species Specificity | 1987 |
[Value of ciprofloxacin in the therapy of tuberculosis and other mycobacterioses].
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium Infections; Ofloxacin; Rifampin | 1997 |
Third-line rescue therapy for Helicobacter pylori infection.
Topics: Anti-Bacterial Agents; Doxycycline; Furazolidone; Helicobacter Infections; Helicobacter pylori; Humans; Ofloxacin; Rifabutin; Rifampin; Treatment Failure | 2006 |
[DNA microarray based rapid drug susceptibility test for Mycobacterium leprae].
Topics: Animals; Dapsone; Drug Resistance, Microbial; Humans; Leprostatic Agents; Leprosy; Mice; Microbial Sensitivity Tests; Mutation; Mycobacterium leprae; Ofloxacin; Oligonucleotide Array Sequence Analysis; Rifampin | 2006 |
Is there a role for rifampicin, ofloxacin and minocycline (ROM) therapy in the treatment of leprosy? Systematic review and meta-analysis.
Topics: Anti-Bacterial Agents; Drug Combinations; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Minocycline; Ofloxacin; Rifampin; Treatment Outcome | 2011 |
Antibiotics for treating human brucellosis.
Topics: Anti-Bacterial Agents; Brucellosis; Ciprofloxacin; Doxycycline; Humans; Ofloxacin; Randomized Controlled Trials as Topic; Rifampin; Streptomycin | 2012 |
World Health Organization (WHO) antibiotic regimen against other regimens for the treatment of leprosy: a systematic review and meta-analysis.
Topics: Adolescent; Adult; Aged; Child; Clinical Protocols; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy, Multibacillary; Leprosy, Paucibacillary; Male; Middle Aged; Minocycline; Mycobacterium leprae; Neglected Diseases; Ofloxacin; Recurrence; Rifampin; Treatment Failure; World Health Organization; Young Adult | 2020 |
Drug Resistance (Dapsone, Rifampicin, Ofloxacin) and Resistance-Related Gene Mutation Features in Leprosy Patients: A Systematic Review and Meta-Analysis.
Topics: Amino Acids; Dapsone; Drug Resistance, Bacterial; Humans; Leprostatic Agents; Leprosy; Microbial Sensitivity Tests; Mutation; Mycobacterium leprae; Ofloxacin; Rifampin | 2022 |
38 trial(s) available for ofloxacin and rifampin
| Article | Year |
|---|---|
A controlled study of rifabutin and an uncontrolled study of ofloxacin in the retreatment of patients with pulmonary tuberculosis resistant to isoniazid, streptomycin and rifampicin. Hong Kong Chest Service/British Medical Research Council.
Topics: Adult; Aged; Antitubercular Agents; Chronic Disease; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Rifabutin; Rifampin; Rifamycins; Sputum; Streptomycin; Treatment Outcome; Tuberculosis, Pulmonary | 1992 |
Prospective comparative study of ofloxacin or ethambutol for the treatment of pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Drug Combinations; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Prospective Studies; Rifampin; Time Factors; Tuberculosis, Pulmonary | 1992 |
A randomized prospective trial of three different regimens of treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Bacteria; Cephalothin; Drug Therapy, Combination; Female; Humans; Injections, Intraperitoneal; Male; Middle Aged; Ofloxacin; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Prospective Studies; Randomized Controlled Trials as Topic; Rifampin; Tobramycin | 1990 |
Quinolones in treatment of human brucellosis: comparative trial of ofloxacin-rifampin versus doxycycline-rifampin.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Brucella melitensis; Brucellosis; Doxycycline; Female; Humans; Male; Middle Aged; Ofloxacin; Prospective Studies; Rifampin; Treatment Outcome | 1993 |
Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants.
Topics: Administration, Oral; Cohort Studies; Drug Therapy, Combination; Hip Prosthesis; Humans; Knee Prosthesis; Ofloxacin; Prospective Studies; Prosthesis-Related Infections; Rifampin; Staphylococcal Infections | 1993 |
Quinolone-based antibacterial chemoprophylaxis in neutropenic patients: effect of augmented gram-positive activity on infectious morbidity. National Cancer Institute of Canada Clinical Trials Group.
Topics: Adult; Aged; Anti-Infective Agents; Antineoplastic Agents; Bacteremia; Colony Count, Microbial; Female; Humans; Male; Middle Aged; Neutropenia; Norfloxacin; Ofloxacin; Rifampin; Staphylococcal Infections; Streptococcal Infections; Treatment Outcome | 1996 |
Combined chemotherapy trials with regimens containing ofloxacin and rifampicin for multibacillary leprosy patients.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Child; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Ofloxacin; Prognosis; Rifampin | 1996 |
Treatment of multidrug-resistant tuberculosis in Indonesia.
Topics: Adult; Drug Resistance, Multiple; Drug Therapy, Combination; Female; Humans; Indonesia; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Nausea; Ofloxacin; Prospective Studies; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant | 1996 |
[Pilot studies on the treatment of Mycobacterium avium complex lung disease--new macrolides and new quinolones. (2) Multi-drug chemotherapy for initial cases on trial].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Humans; Kanamycin; Mycobacterium avium-intracellulare Infection; Ofloxacin; Pilot Projects; Rifampin; Tuberculosis, Pulmonary | 1996 |
Leucocytopenia after rifampicin and ofloxacin therapy in leprosy.
Topics: Adolescent; Adult; Aged; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy, Borderline; Leprosy, Tuberculoid; Leukopenia; Male; Middle Aged; Ofloxacin; Rifampin | 1997 |
Field trial on efficacy of supervised monthly dose of 600 mg rifampin, 400 mg ofloxacin and 100 mg minocycline for the treatment of leprosy; first results.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Child; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Minocycline; Ofloxacin; Rifampin | 1997 |
High relapse rate among lepromatous leprosy patients treated with rifampin plus ofloxacin daily for 4 weeks.
Topics: Adult; Anti-Infective Agents; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Middle Aged; Ofloxacin; Recurrence; Rifampin | 1997 |
Susceptibility to levofloxacin of Myocobacterium tuberculosis isolates from patients with HIV-related tuberculosis and characterization of a strain with levofloxacin monoresistance. Community Programs for Clinical Research on AIDS 019 and the AIDS Clinica
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; In Vitro Techniques; Isoniazid; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Rifampin; Sputum; Tuberculosis | 1997 |
Rifampicin/minocycline and ofloxacin (ROM) for single lesions--what is the evidence?
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Drug Combinations; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Minocycline; Ofloxacin; Rifampin; Treatment Outcome; World Health Organization | 1997 |
Bactericidal activity of a single-dose combination of ofloxacin plus minocycline, with or without rifampin, against Mycobacterium leprae in mice and in lepromatous patients.
Topics: Adolescent; Adult; Animals; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy; Male; Mice; Mice, Nude; Middle Aged; Minocycline; Mycobacterium leprae; Ofloxacin; Rifampin | 1998 |
Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Tr
Topics: Adult; AIDS-Related Opportunistic Infections; Antitubercular Agents; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Levofloxacin; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Recurrence; Rifampin; Sputum; Treatment Outcome; Tuberculosis, Pulmonary | 1998 |
Single-dose rifampicin, oflaxicin and minocycline (ROM) therapy for single leprosy lesions.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy; Male; Minocycline; Ofloxacin; Rifampin; Treatment Outcome | 1998 |
Ofloxacin containing combined drug regimens in the treatment of multibacillary leprosy.
Topics: Adolescent; Adult; Aged; Animals; Child; Dose-Response Relationship, Drug; Female; Humans; Leprostatic Agents; Leprosy; Male; Mice; Mice, Nude; Middle Aged; Ofloxacin; Rifampin; Thailand; Time Factors; Treatment Outcome | 1997 |
A 6 week quadruple drug regimen for the treatment of multibacillary leprosy.
Topics: Clofazimine; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy; Male; Minocycline; Mycobacterium leprae; Ofloxacin; Rifampin; Treatment Outcome | 2000 |
A multicentre study of the early bactericidal activity of anti-tuberculosis drugs.
Topics: Adult; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Colony Count, Microbial; Hong Kong; Humans; India; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; South Africa; Sputum; Tuberculosis, Pulmonary | 2000 |
Efficacy of single-dose ROM therapy plus low-dose convit vaccine as an adjuvant for treatment of paucibacillary leprosy patients with a single skin lesion.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Vaccines; Drug Therapy, Combination; Female; Humans; India; Leprostatic Agents; Leprosy, Lepromatous; Male; Middle Aged; Minocycline; Mycobacterium leprae; Ofloxacin; Rifampin | 2000 |
Distinct histopathological patterns in single lesion leprosy patients treated with single dose therapy (ROM) in the Brazilian Multicentric Study.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Biopsy; Cohort Studies; Drug Therapy, Combination; Female; Histocytochemistry; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Middle Aged; Minocycline; Mycobacterium leprae; Neuritis; Ofloxacin; Rifampin | 2001 |
Parallel assessment of 24 monthly doses of rifampin, ofloxacin, and minocycline versus two years of World Health Organization multi-drug therapy for multi-bacillary leprosy.
Topics: Adolescent; Adult; Clofazimine; Dapsone; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Minocycline; Ofloxacin; Rifampin | 2004 |
Ofloxacin plus rifampicin versus doxycycline plus rifampicin in the treatment of brucellosis: a randomized clinical trial [ISRCTN11871179].
Topics: Adolescent; Adult; Brucellosis; Diarrhea; Doxycycline; Drug Costs; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nausea; Ofloxacin; Rifampin; Time Factors; Treatment Outcome | 2004 |
Disposition of uric acid upon administration of ofloxacin alone and in combination with other anti-tuberculosis drugs.
Topics: Adult; Antitubercular Agents; Clinical Trials as Topic; Humans; Isoniazid; Male; Ofloxacin; Pyrazinamide; Rifampin; Uric Acid | 2004 |
Antimicrobial chemotherapy for Legionnaires disease: levofloxacin versus macrolides.
Topics: Anti-Bacterial Agents; Case-Control Studies; Disease Outbreaks; Drug Therapy, Combination; Female; Humans; Legionnaires' Disease; Levofloxacin; Macrolides; Male; Middle Aged; Ofloxacin; Rifampin | 2005 |
Comparison of three different combination therapies in the treatment of human brucellosis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Brucella; Brucellosis; Doxycycline; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Ofloxacin; Rifampin; Streptomycin; Treatment Outcome | 2005 |
Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment: a prospective and randomized clinical trial of 381 patients.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Chi-Square Distribution; Drug Therapy, Combination; Female; Finland; Humans; Levofloxacin; Male; Middle Aged; Odds Ratio; Ofloxacin; Penicillins; Prospective Studies; Rifampin; Sepsis; Staphylococcal Infections; Staphylococcus aureus; Treatment Failure | 2006 |
A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antitubercular Agents; Aza Compounds; Colony Count, Microbial; Drug Therapy, Combination; Female; Fluoroquinolones; Gatifloxacin; Humans; Isoniazid; Male; Middle Aged; Moxifloxacin; Nonlinear Dynamics; Ofloxacin; Pyrazinamide; Quinolines; Rifampin; Sputum | 2008 |
Serological response to chemoprophylaxis in extended contacts in leprosy--a randomized controlled trial.
Topics: Adolescent; Adult; Antibiotic Prophylaxis; Antibodies, Bacterial; Child; Cohort Studies; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Follow-Up Studies; Humans; Immunoglobulin M; Leprostatic Agents; Leprosy; Minocycline; Myanmar; Mycobacterium leprae; Ofloxacin; Rifampin; Risk; Seroepidemiologic Studies; Time Factors | 2008 |
The efficacy of a four-week, ofloxacin-containing regimen compared with standard WHO-MDT in PB leprosy.
Topics: Adult; Dapsone; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy, Paucibacillary; Male; Middle Aged; Ofloxacin; Recurrence; Rifampin; Skin; Time Factors; Treatment Outcome; World Health Organization | 2010 |
Intensified treatment with high dose rifampicin and levofloxacin compared to standard treatment for adult patients with tuberculous meningitis (TBM-IT): protocol for a randomized controlled trial.
Topics: Adult; Antitubercular Agents; Disability Evaluation; Double-Blind Method; Drug Therapy, Combination; HIV Infections; Humans; Levofloxacin; Neurologic Examination; Ofloxacin; Research Design; Rifampin; Sample Size; Time Factors; Treatment Outcome; Tuberculosis, Meningeal; Vietnam | 2011 |
Sample size requirements for separating out the effects of combination treatments: randomised controlled trials of combination therapy vs. standard treatment compared to factorial designs for patients with tuberculous meningitis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Data Interpretation, Statistical; Drug Synergism; Drug Therapy, Combination; Humans; Ofloxacin; Research Design; Rifampin; Sample Size; Tuberculosis, Meningeal | 2011 |
Randomized pharmacokinetic and pharmacodynamic comparison of fluoroquinolones for tuberculous meningitis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Ciprofloxacin; Ethambutol; Female; Fluoroquinolones; Gatifloxacin; Humans; Injections, Intramuscular; Isoniazid; Levofloxacin; Male; Middle Aged; Multivariate Analysis; Ofloxacin; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Meningeal; Young Adult | 2011 |
A randomised controlled trial assessing the effect of adding clarithromycin to rifampicin, ofloxacin and minocycline in the treatment of single lesion paucibacillary leprosy in Agra District, India.
Topics: Adolescent; Adult; Child; Child, Preschool; Clarithromycin; Female; Humans; India; Leprosy, Paucibacillary; Male; Middle Aged; Minocycline; Ofloxacin; Recurrence; Rifampin; Survival Analysis; Treatment Outcome | 2011 |
Comparison of doxycycline-streptomycin, doxycycline-rifampin, and ofloxacin-rifampin in the treatment of brucellosis: a randomized clinical trial.
Topics: Adult; Anti-Bacterial Agents; Brucella melitensis; Brucellosis; Doxycycline; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Multivariate Analysis; Ofloxacin; Rifampin; Streptomycin; Treatment Outcome; Young Adult | 2012 |
OFLOXACIN multicentre trial in MB leprosy FUAM-Manaus and ILSL-Bauru, Brazil.
Topics: Adolescent; Adult; Animals; Brazil; Clofazimine; Dapsone; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy, Multibacillary; Male; Mice; Middle Aged; Mycobacterium leprae; Ofloxacin; Prevalence; Rifampin; Secondary Prevention; Skin; Time Factors; Treatment Outcome; World Health Organization; Young Adult | 2012 |
Oral antimycobacterial therapy in chronic cutaneous sarcoidosis: a randomized, single-masked, placebo-controlled study.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Azithromycin; CD4-Positive T-Lymphocytes; Chronic Disease; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Rifampin; Sarcoidosis; Severity of Illness Index; Single-Blind Method; Skin Diseases; Transcriptome; Treatment Outcome; Young Adult | 2013 |
301 other study(ies) available for ofloxacin and rifampin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Low-oxygen-recovery assay for high-throughput screening of compounds against nonreplicating Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; DNA, Bacterial; Drug Evaluation, Preclinical; Mycobacterium tuberculosis; Oxygen | 2007 |
Synthesis and biological evaluation of new N-(2-hydroxy-4(or 5)-nitro/aminophenyl)benzamides and phenylacetamides as antimicrobial agents.
Topics: Anti-Bacterial Agents; Antifungal Agents; Benzamides; Microbial Sensitivity Tests; Spectroscopy, Fourier Transform Infrared; Structure-Activity Relationship | 2007 |
Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms.
Topics: Animals; Anti-Bacterial Agents; Biofilms; CHO Cells; Cricetinae; Cricetulus; DNA-Directed RNA Polymerases; Furans; Gram-Positive Bacteria; Microbial Sensitivity Tests; Rhodanine; Staphylococcus epidermidis; Structure-Activity Relationship | 2007 |
Synergy between polyethylenimine and different families of antibiotics against a resistant clinical isolate of Pseudomonas aeruginosa.
Topics: Aminoglycosides; Anti-Bacterial Agents; Carbenicillin; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Drug Synergism; Humans; Microbial Sensitivity Tests; Novobiocin; Ofloxacin; Piperacillin; Polyethyleneimine; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Ticarcillin; Tobramycin | 2008 |
Synthesis, antimicrobial activity, pharmacophore analysis of some new 2-(substitutedphenyl/benzyl)-5-[(2-benzofuryl)carboxamido]benzoxazoles.
Topics: Amides; Anti-Bacterial Agents; Benzofurans; Benzoxazoles; Microbial Viability; Molecular Structure; Structure-Activity Relationship | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Synthesis, biological evaluation and 2D-QSAR analysis of benzoxazoles as antimicrobial agents.
Topics: Anti-Infective Agents; Bacteria; Benzoxazoles; Candida albicans; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Quantitative Structure-Activity Relationship | 2009 |
Functional cloning and characterization of the multidrug efflux pumps NorM from Neisseria gonorrhoeae and YdhE from Escherichia coli.
Topics: Anti-Bacterial Agents; Antiporters; ATP-Binding Cassette Transporters; Bacterial Proteins; Cloning, Molecular; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Proteins; Ethidium; Fluorescence Polarization; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin | 2008 |
Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France.
Topics: Aged; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Female; Fluoroquinolones; France; Genes, Bacterial; Humans; Models, Genetic; Molecular Sequence Data; Plasmids | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.
Topics: Antitubercular Agents; BCG Vaccine; Microbial Sensitivity Tests; Mycobacterium bovis | 2009 |
Use of a surface plasmon resonance method to investigate antibiotic and plasma protein interactions.
Topics: Anti-Bacterial Agents; Blood Proteins; Protein Binding; Surface Plasmon Resonance | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Pentacyclo-undecane derived cyclic tetra-amines: synthesis and evaluation as potent anti-tuberculosis agents.
Topics: Alkanes; Animals; Antitubercular Agents; Cattle; Cell Line; Cell Survival; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Prenylation | 2009 |
Horizontal transfer of tetracycline resistance among Chlamydia spp. in vitro.
Topics: Chlamydia; Fluorescent Antibody Technique; Gene Transfer, Horizontal; Ofloxacin; Recombination, Genetic; Rifampin; Tetracycline Resistance | 2009 |
Modifying culture conditions in chemical library screening identifies alternative inhibitors of mycobacteria.
Topics: Antitubercular Agents; Cysteine; Drug Evaluation, Preclinical; Mycobacterium; Mycobacterium smegmatis; Organoselenium Compounds; Selenocysteine; Small Molecule Libraries | 2009 |
Discovery of novel antitubercular 2,10-dihydro-4aH-chromeno[3,2-c]pyridin-3-yl derivatives.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Drug Discovery; Microbial Sensitivity Tests; Pyridines; Vero Cells | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Emergence and molecular characterization of extensively drug-resistant Mycobacterium tuberculosis clinical isolates from the Delhi Region in India.
Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; DNA Gyrase; DNA Mutational Analysis; DNA-Directed RNA Polymerases; Extensively Drug-Resistant Tuberculosis; Fluoroquinolones; India; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Point Mutation; Polymerase Chain Reaction; Rifampin | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Antimycobacterial activity of bisbenzylisoquinoline alkaloids from Tiliacora triandra against multidrug-resistant isolates of Mycobacterium tuberculosis.
Topics: Alkaloids; Antitubercular Agents; Benzylisoquinolines; Drug Resistance, Multiple, Bacterial; Humans; Magnetic Resonance Spectroscopy; Menispermaceae; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Plant Extracts; Plant Roots; Tuberculosis, Multidrug-Resistant | 2012 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
Synthesis and antimycobacterial activity of novel 1,3-dimethylisocyanurate derivatives.
Topics: Amides; Animals; Anti-Bacterial Agents; Chemistry Techniques, Synthetic; Mice; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Rats; Structure-Activity Relationship; Sulfonic Acids; Triazines | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
The synthesis and antituberculosis activity of 5'-nor carbocyclic uracil derivatives.
Topics: Animals; Antitubercular Agents; Cell Survival; Chlorocebus aethiops; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Stereoisomerism; Uracil; Vero Cells | 2012 |
Inhibition of Mycobacterium tuberculosis strains H37Rv and MDR MS-115 by a new set of C5 modified pyrimidine nucleosides.
Topics: Animals; Antitubercular Agents; Cell Line, Tumor; Cell Survival; Chlorocebus aethiops; Humans; Jurkat Cells; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrimidine Nucleosides; Structure-Activity Relationship; Vero Cells | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Hytramycins V and I, anti-Mycobacterium tuberculosis hexapeptides from a Streptomyces hygroscopicus strain.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Chromatography, High Pressure Liquid; Inhibitory Concentration 50; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nuclear Magnetic Resonance, Biomolecular; Peptides, Cyclic; Streptomyces; Vero Cells | 2013 |
Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosis.
Topics: Acute Disease; Administration, Oral; Animals; Antitubercular Agents; Bacterial Proteins; Biological Availability; Chronic Disease; DNA Gyrase; Drug Resistance, Bacterial; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Fluoroquinolones; Humans; Macrophages; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Docking Simulation; Mutation; Mycobacterium tuberculosis; Piperidines; Protein Subunits; Rats; Stereoisomerism; Structure-Activity Relationship; Topoisomerase II Inhibitors; Tuberculosis, Pulmonary | 2014 |
Discovery of pyrazolopyridones as a novel class of noncovalent DprE1 inhibitor with potent anti-mycobacterial activity.
Topics: Alcohol Oxidoreductases; Antitubercular Agents; Bacterial Proteins; Catalytic Domain; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Molecular Docking Simulation; Mutation; Mycobacterium tuberculosis; Oxidoreductases; Pyrazoles; Pyridones; Structure-Activity Relationship | 2014 |
1-Substituted-5-[(3,5-dinitrobenzyl)sulfanyl]-1H-tetrazoles and their isosteric analogs: A new class of selective antitubercular agents active against drug-susceptible and multidrug-resistant mycobacteria.
Topics: Antineoplastic Agents; Antitubercular Agents; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Drug Screening Assays, Antitumor; HeLa Cells; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Nitrobenzenes; Structure-Activity Relationship; Triazoles; Tumor Cells, Cultured | 2014 |
Development of 2-(4-oxoquinazolin-3(4H)-yl)acetamide derivatives as novel enoyl-acyl carrier protein reductase (InhA) inhibitors for the treatment of tuberculosis.
Topics: Acetamides; Animals; Bacterial Proteins; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Oxidoreductases; Quinazolines; Structure-Activity Relationship; Tuberculosis | 2014 |
Development of benzo[d]oxazol-2(3H)-ones derivatives as novel inhibitors of Mycobacterium tuberculosis InhA.
Topics: Animals; Antitubercular Agents; Bacterial Proteins; Benzoxazoles; Cell Line; Humans; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Oxidoreductases; Structure-Activity Relationship; Tuberculosis | 2014 |
An efficient synthesis and biological screening of benzofuran and benzo[d]isothiazole derivatives for Mycobacterium tuberculosis DNA GyrB inhibition.
Topics: Animals; Antitubercular Agents; Benzofurans; Benzothiazoles; Cell Line; DNA Gyrase; Dose-Response Relationship, Drug; Humans; Macrophages; Mice; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Piperazines; Structure-Activity Relationship; Topoisomerase II Inhibitors | 2014 |
Antimycobacterial activity of natural products and synthetic agents: pyrrolodiquinolines and vermelhotin as anti-tubercular leads against clinical multidrug resistant isolates of Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Biological Products; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyrrolidines; Quinolines; Structure-Activity Relationship | 2015 |
Eremophilane Sesquiterpenes and Diphenyl Thioethers from the Soil Fungus Penicillium copticola PSU-RSPG138.
Topics: Animals; Antimalarials; Antineoplastic Agents; Biphenyl Compounds; Chlorocebus aethiops; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Molecular Structure; Penicillium; Plasmodium falciparum; Sesquiterpenes; Soil Microbiology; Sulfides; Thailand; Vero Cells | 2015 |
Development of 2-amino-5-phenylthiophene-3-carboxamide derivatives as novel inhibitors of Mycobacterium tuberculosis DNA GyrB domain.
Topics: Antitubercular Agents; DNA Gyrase; Drug Discovery; Humans; Mycobacterium smegmatis; Mycobacterium tuberculosis | 2015 |
Hybrid triazoles: Design and synthesis as potential dual inhibitor of growth and efflux inhibition in tuberculosis.
Topics: Antitubercular Agents; Cells, Cultured; Chemistry Techniques, Synthetic; Drug Design; Drug Evaluation, Preclinical; Drug Synergism; Extensively Drug-Resistant Tuberculosis; Humans; Macrophages; Microbial Sensitivity Tests; Mycobacterium smegmatis; Mycobacterium tuberculosis; Triazoles | 2016 |
Development of 3,5-Dinitrobenzylsulfanyl-1,3,4-oxadiazoles and Thiadiazoles as Selective Antitubercular Agents Active Against Replicating and Nonreplicating Mycobacterium tuberculosis.
Topics: Animals; Antitubercular Agents; Bacteria; Cell Line; Cell Survival; Drug Design; Drug Resistance, Multiple, Bacterial; Fungi; Humans; Latent Tuberculosis; Microbial Sensitivity Tests; Microsomes; Mutagens; Mycobacterium tuberculosis; Oxazoles; Primary Cell Culture; Rifampin; Structure-Activity Relationship; Thiadiazoles | 2016 |
Lovastatin Analogues from the Soil-Derived Fungus Aspergillus sclerotiorum PSU-RSPG178.
Topics: Animals; Aspergillus; Chlorocebus aethiops; Crystallography, X-Ray; Drug Screening Assays, Antitumor; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inhibitory Concentration 50; KB Cells; Lovastatin; Microbial Sensitivity Tests; Molecular Conformation; Mycobacterium scrofulaceum; Nuclear Magnetic Resonance, Biomolecular; Plasmodium falciparum; Soil Microbiology; Thailand; Vero Cells | 2016 |
Engineering another class of anti-tubercular lead: Hit to lead optimization of an intriguing class of gyrase ATPase inhibitors.
Topics: Adenosine Triphosphatases; Antitubercular Agents; DNA Gyrase; Drug Discovery; Engineering; Microbial Sensitivity Tests; Models, Molecular; Mycobacterium tuberculosis; Protein Conformation | 2016 |
S-substituted 3,5-dinitrophenyl 1,3,4-oxadiazole-2-thiols and tetrazole-5-thiols as highly efficient antitubercular agents.
Topics: Antifungal Agents; Antitubercular Agents; Drug Design; Drug Resistance; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Oxadiazoles; Structure-Activity Relationship; Sulfhydryl Compounds; Tetrazoles | 2017 |
Synthesis, antimycobacterial and cytotoxic activity of α,β-unsaturated amides and 2,4-disubstituted oxazoline derivatives.
Topics: Amides; Animals; Antitubercular Agents; Liver; Microbial Sensitivity Tests; Microscopy; Mycobacterium tuberculosis; Oxazoles; Rats; Structure-Activity Relationship | 2017 |
Development of water-soluble 3,5-dinitrophenyl tetrazole and oxadiazole antitubercular agents.
Topics: Antitubercular Agents; Caco-2 Cells; Cell Line; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Oxadiazoles; Solubility; Structure-Activity Relationship; Tetrazoles; Water | 2017 |
Synthesis and evaluation of 4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran] analogues against both active and dormant Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Dose-Response Relationship, Drug; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Pyrans; Spiro Compounds; Structure-Activity Relationship; Thiophenes | 2018 |
Design, synthesis, and biological evaluation of
Topics: | 2018 |
Identification of Novel Coumestan Derivatives as Polyketide Synthase 13 Inhibitors against Mycobacterium tuberculosis. Part II.
Topics: Animals; Antitubercular Agents; Chlorocebus aethiops; Coumarins; Crystallography, X-Ray; Drug Resistance, Bacterial; Enzyme Inhibitors; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Polyketide Synthases; Structure-Activity Relationship; Vero Cells | 2019 |
Synthesis and antimycobacterial activity of imidazo[1,2-b][1,2,4,5]tetrazines.
Topics: Antitubercular Agents; Drug Resistance, Microbial; Erythromycin; Heterocyclic Compounds, 2-Ring; Imidazoles; Imipenem; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium smegmatis; Mycobacterium tuberculosis; Ofloxacin; Protein Serine-Threonine Kinases; Rifampin | 2019 |
Design of Trp-Rich Dodecapeptides with Broad-Spectrum Antimicrobial Potency and Membrane-Disruptive Mechanism.
Topics: Anti-Infective Agents; Antimicrobial Cationic Peptides; Bacterial Outer Membrane; Drug Design; Escherichia coli; Humans; Microbial Sensitivity Tests; Oligopeptides; Peptide Fragments; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Staphylococcus aureus; Tryptophan | 2019 |
Development of 3,5-Dinitrophenyl-Containing 1,2,4-Triazoles and Their Trifluoromethyl Analogues as Highly Efficient Antitubercular Agents Inhibiting Decaprenylphosphoryl-β-d-ribofuranose 2'-Oxidase.
Topics: Alcohol Oxidoreductases; Antitubercular Agents; Bacterial Proteins; Dinitrobenzenes; Dose-Response Relationship, Drug; Drug Development; Hydrocarbons, Fluorinated; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Structure-Activity Relationship; Triazoles | 2019 |
Synthesis and evaluation of 1,3,4-oxadiazole derivatives for development as broad-spectrum antibiotics.
Topics: Anti-Bacterial Agents; Cell Line, Tumor; Cell Survival; Drug Design; Drug Synergism; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Oxadiazoles | 2019 |
Phenanthrolinic analogs of quinolones show antibacterial activity against M. tuberculosis.
Topics: Antitubercular Agents; Drug Design; Drug Resistance, Bacterial; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phenanthrolines; Quinolones | 2020 |
Design and synthesis of mycobacterial pks13 inhibitors: Conformationally rigid tetracyclic molecules.
Topics: Antitubercular Agents; Bacterial Proteins; Dose-Response Relationship, Drug; Drug Design; Enzyme Inhibitors; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Mycobacterium tuberculosis; Polyketide Synthases; Quinolones; Structure-Activity Relationship | 2021 |
Tolerance of ofloxacin in the treatment of pulmonary tuberculosis in presence of hepatic dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Drug Monitoring; Drug Therapy, Combination; Female; Humans; Isoniazid; Liver Function Tests; Male; Middle Aged; Ofloxacin; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1992 |
Bactericidal activities of single or multiple doses of various combinations of new antileprosy drugs and/or rifampin against M. leprae in mice.
Topics: Animals; Clarithromycin; Disease Models, Animal; Female; Fluoroquinolones; Foot; Hindlimb; Immunocompetence; Leprostatic Agents; Leprosy; Mice; Microbial Sensitivity Tests; Minocycline; Mycobacterium leprae; Ofloxacin; Quinolones; Rifampin | 1992 |
An experimental study to evaluate the bactericidal activity of ofloxacin against an established Mycobacterium leprae infection.
Topics: Animals; Dapsone; Disease Models, Animal; Drug Therapy, Combination; Leprosy; Mice; Mice, Nude; Mycobacterium leprae; Ofloxacin; Rifampin; Serum Bactericidal Test | 1992 |
Therapy of experimental murine brucellosis with streptomycin, co-trimoxazole, ciprofloxacin, ofloxacin, pefloxacin, doxycycline, and rifampin.
Topics: Administration, Oral; Animals; Brucellosis; Ciprofloxacin; Doxycycline; Injections, Intraperitoneal; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Ofloxacin; Pefloxacin; Rifampin; Streptomycin; Trimethoprim, Sulfamethoxazole Drug Combination | 1992 |
Can leprosy be neutralized by year 2000?
Topics: Bacterial Vaccines; Global Health; Humans; Leprosy; Mycobacterium leprae; Ofloxacin; Prevalence; Rifampin | 1992 |
[Renal tuberculosis treated with rifampicin, isoniazid and ofloxacin].
Topics: Adolescent; Adult; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Isoniazid; Male; Middle Aged; Ofloxacin; Rifampin; Tuberculosis, Renal | 1992 |
In-vitro activity of ofloxacin against Mycobacterium tuberculosis and its clinical efficacy in multiply resistant pulmonary tuberculosis.
Topics: Adult; Aged; Anti-Bacterial Agents; Drug Resistance, Microbial; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Sputum; Streptomycin; Tuberculosis, Pulmonary | 1990 |
[Chemotherapeutic regimens for nontuberculous mycobacterial infection based on in-vitro susceptibility test results].
Topics: Drug Resistance, Microbial; Drug Therapy, Combination; Enviomycin; Ethambutol; Humans; Isoniazid; Mycobacterium; Mycobacterium Infections; Ofloxacin; Rifampin; Viomycin | 1990 |
Susceptibilities of Mycobacterium leprae and M. avium complex to the H2O2-Fe-mediated halogenation system supplemented with antimicrobial agents.
Topics: Animals; Clofazimine; Dapsone; Ethidium; Ferrous Compounds; Fluoresceins; Humans; Hydrogen Peroxide; Iodides; Mice; Mycobacterium avium Complex; Mycobacterium leprae; Ofloxacin; Rifampin; Sodium Iodide; Staining and Labeling | 1989 |
[Rifabutine in the treatment of mycobacterial infections resistant to rifampicin. Preliminary results. Group for the Study and Treatment of Resistant Mycobacterial Infections (GETIM)].
Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Ofloxacin; Rifabutin; Rifampin; Rifamycins; Tuberculosis, Pulmonary | 1989 |
Mycobacterium simiae as a cause of intra-abdominal disease: a case report.
Topics: Abdomen; Adult; Ascitic Fluid; Drug Therapy, Combination; Female; Humans; Isoniazid; Kanamycin; Mycobacterium; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ofloxacin; Pyrazinamide; Rifampin | 1989 |
[Rickettsiaceae infections and fluoroquinolones].
Topics: Administration, Oral; Adult; Aged; Anti-Infective Agents; Boutonneuse Fever; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Male; Middle Aged; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Pregnancy; Q Fever; Rifampin | 1988 |
Ofloxacin: bactericidal effect in an in vitro pharmacokinetic model.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteria; Cefaclor; Escherichia coli; Humans; Kinetics; Ofloxacin; Oxazines; Proteus; Pseudomonas aeruginosa; Rifampin; Staphylococcus aureus | 1986 |
In vitro susceptibility of Mycobacterium tuberculosis to ofloxacin and ciprofloxacin in combination with rifampin and isoniazid.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Synergism; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Oxazines; Rifampin | 1987 |
[Corynebacterium group D2. Clinical study, biochemical identification and antibiotic sensitivity].
Topics: Anti-Bacterial Agents; Ciprofloxacin; Corynebacterium; Corynebacterium Infections; Drug Resistance, Microbial; Enoxacin; Female; Humans; Male; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Peptides, Cyclic; Pipemidic Acid; Rifampin; Tetracycline; Tetracycline Resistance; Urinary Tract Infections; Vancomycin; Virginiamycin | 1988 |
Effectiveness of ofloxacin against Mycobacterium tuberculosis and Mycobacterium avium, and rifampin against M. tuberculosis in cultured human macrophages.
Topics: Cells, Cultured; Colony Count, Microbial; Culture Media; Humans; In Vitro Techniques; Macrophages; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Time Factors | 1988 |
[Ofloxacin (RU 43280). Clinical study].
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Drug Therapy, Combination; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Ofloxacin; Oxazines; Respiratory Tract Infections; Rifampin; Staphylococcal Infections; Urinary Tract Infections | 1987 |
[Antituberculosis chemotherapy including ofloxacin in patients with pulmonary tuberculosis not treated previously].
Topics: Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Ofloxacin; Oxazines; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1986 |
Intraphagocytic bactericidal activity of ofloxacin compared with that of aztreonam and ceftriaxone against Serratia marcescens.
Topics: Aztreonam; Ceftriaxone; Escherichia coli; Humans; Ofloxacin; Oxazines; Phagocytes; Phagocytosis; Rifampin; Serratia marcescens | 1986 |
Inhibitory and bactericidal activities of levofloxacin, ofloxacin, erythromycin, and rifampin used singly and in combination against Legionella pneumophila.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Drug Synergism; Drug Therapy, Combination; Erythromycin; Humans; Legionella pneumophila; Legionnaires' Disease; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Rifampin; Time Factors | 1995 |
Failure of drug penetration and acquisition of drug resistance in chronic tuberculous empyema.
Topics: Aged; Antitubercular Agents; Chronic Disease; Empyema, Tuberculous; Ethambutol; Humans; Male; Ofloxacin; Pleural Effusion; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 1995 |
Assessment of mycobacterial viability by RNA amplification.
Topics: DNA, Bacterial; Gene Amplification; Kinetics; Mycobacterium; Ofloxacin; Polymerase Chain Reaction; Rifampin; RNA, Bacterial; RNA, Ribosomal, 16S | 1994 |
[Recurrent lepromatous leprosy in conventional triple therapy: value of the rifampicin-ofloxacin combination].
Topics: Aged; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Ofloxacin; Recurrence; Rifampin | 1995 |
The in-vitro activities of novel benzoxazinorifamycins against Mycobacterium leprae.
Topics: Adenosine Triphosphate; Culture Media; Drug Resistance, Microbial; Drug Synergism; Leprostatic Agents; Microbial Sensitivity Tests; Mycobacterium leprae; Ofloxacin; Rifabutin; Rifampin; Rifamycins; Thymidine | 1995 |
Pharmacodynamics of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with rifampin, against methicillin-susceptible and -resistant Staphylococcus aureus in an in vitro infection model.
Topics: Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Rifampin; Staphylococcus aureus; Stereoisomerism | 1994 |
In vivo susceptibility of Mycobacterium leprae to ofloxacin either singly or in combination with rifampicin and rifabutin. Anti-leprosy activity of ofloxacin and ansamycins in mice.
Topics: Animals; Armadillos; Drug Synergism; Female; Foot; Leprostatic Agents; Leprosy; Liver; Mice; Mice, Inbred BALB C; Mycobacterium leprae; Ofloxacin; Rifabutin; Rifampin | 1994 |
Activities of roxithromycin used alone and in combination with ethambutol, rifampin, amikacin, ofloxacin, and clofazimine against Mycobacterium avium complex.
Topics: Amikacin; Clofazimine; Drug Synergism; Ethambutol; Humans; Microbial Sensitivity Tests; Mycobacterium avium Complex; Ofloxacin; Rifampin; Roxithromycin | 1994 |
Antagonism between bactericidal activities of 4-quinolones and coumarins gives insight into 4-quinolone killing mechanisms.
Topics: Aminocoumarins; Anti-Infective Agents; Ciprofloxacin; Coumarins; DNA Topoisomerases, Type II; Escherichia coli; Genes, Bacterial; Microbial Sensitivity Tests; Mutation; Nalidixic Acid; Norfloxacin; Novobiocin; Ofloxacin; Rifampin | 1994 |
Unsuccessful treatment of Legionella pneumophila infection with a fluoroquinolone.
Topics: AIDS-Related Opportunistic Infections; Anti-Infective Agents; Drug Therapy, Combination; Erythromycin; Humans; Legionnaires' Disease; Male; Middle Aged; Ofloxacin; Rifampin | 1993 |
[Mixte community-acquired Legionella pneumophila and Staphylococcus aureus pneumonia].
Topics: Adult; Community-Acquired Infections; Drug Therapy, Combination; Female; Humans; Legionnaires' Disease; Ofloxacin; Pneumonia, Staphylococcal; Rifampin; Staphylococcus aureus | 1993 |
Brucellosis of the spine.
Topics: Adolescent; Adult; Aged; Brucella melitensis; Brucellosis; Combined Modality Therapy; Diagnosis, Differential; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Immobilization; Male; Middle Aged; Neurologic Examination; Ofloxacin; Osteomyelitis; Rifampin; Spine; Spondylitis; Tomography, X-Ray Computed | 1993 |
In vitro synergistic activity between ofloxacin and ansamycins against Mycobacterium leprae.
Topics: Animals; Anti-Bacterial Agents; Armadillos; Drug Synergism; Humans; Lactams, Macrocyclic; Microbial Sensitivity Tests; Mycobacterium leprae; Ofloxacin; Rifabutin; Rifampin; Rifamycins | 1993 |
Therapeutic efficacy of some new quinolones and a combination of ofloxacin with rifampin against Mycobacterium leprae infection induced in athymic nude mice.
Topics: Animals; Disease Models, Animal; Drug Therapy, Combination; Female; Leprosy; Mice; Mice, Inbred BALB C; Mice, Nude; Ofloxacin; Quinolones; Rifampin | 1993 |
[Evaluation of 18 epididymo-orchitis cases].
Topics: Adolescent; Adult; Bacteriuria; Brucellosis; Doxycycline; Drug Therapy, Combination; Epididymitis; Escherichia coli; Escherichia coli Infections; Humans; Male; Middle Aged; Ofloxacin; Orchitis; Prospective Studies; Rifampin | 1993 |
In vitro antimicrobial effect against Streptococcus pneumoniae of adding rifampin to penicillin, ceftriaxone, or 1-ofloxacin.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Cephalosporins; Colony Count, Microbial; Humans; Microbial Sensitivity Tests; Ofloxacin; Penicillin G; Pneumococcal Infections; Rifampin; Streptococcus pneumoniae | 1995 |
In vitro activity of a new rifamycin derivative against Mycobacterium leprae.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Armadillos; Drug Interactions; Leprostatic Agents; Microbial Sensitivity Tests; Mycobacterium leprae; Ofloxacin; Rifabutin; Rifampin; Rifamycins | 1996 |
Bactericidal activities of combinations of new drugs against Mycobacterium leprae in nude mice.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Clarithromycin; Colony Count, Microbial; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Female; Leprostatic Agents; Leprosy; Mice; Mice, Nude; Minocycline; Mycobacterium leprae; Ofloxacin; Rifampin | 1996 |
Insufficient evidence of synergistic effect of levofloxacin and rifampin against Legionella pneumophila.
Topics: Anti-Infective Agents; Antibiotics, Antitubercular; Drug Synergism; Legionella pneumophila; Levofloxacin; Ofloxacin; Rifampin | 1996 |
Pharmacodynamics of once- or twice-daily levofloxacin versus vancomycin, with or without rifampin, against Staphylococcus aureus in an in vitro model with infected platelet-fibrin clots.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Blood Platelets; Colony Count, Microbial; Fibrin; Humans; Levofloxacin; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Rifampin; Staphylococcus aureus; Vancomycin | 1996 |
Bactericidal action of ofloxacin, sulbactam-ampicillin, rifampin, and isoniazid on logarithmic- and stationary-phase cultures of Mycobacterium tuberculosis.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Colony Count, Microbial; Drug Therapy, Combination; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Penicillins; Rifampin; Sulbactam | 1996 |
Spectrum of activity of levofloxacin against nontuberculous mycobacteria and its activity against the Mycobacterium avium complex in combination with ethambutol, rifampin, roxithromycin, amikacin, and clofazimine.
Topics: Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Clofazimine; Drug Combinations; Ethambutol; Humans; Levofloxacin; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium avium Complex; Ofloxacin; Rifampin; Roxithromycin | 1996 |
Comparative activities of new fluoroquinolones, alone or in combination with amoxicillin, trimethoprim-sulfamethoxazole, or rifampin, against intracellular Listeria monocytogenes.
Topics: Amoxicillin; Anti-Infective Agents; Colony Count, Microbial; Dose-Response Relationship, Drug; Fluoroquinolones; HeLa Cells; Humans; Levofloxacin; Listeria monocytogenes; Ofloxacin; Quinolones; Rifampin; Sulfamethoxazole; Trimethoprim | 1997 |
Pharmacodynamic effects of antibiotics and antibiotic combinations on growing and nongrowing Staphylococcus epidermidis cells.
Topics: Amikacin; Anti-Bacterial Agents; Drug Synergism; Drug Therapy, Combination; Imipenem; Microbial Sensitivity Tests; Ofloxacin; Rifampin; Staphylococcus epidermidis; Vancomycin | 1997 |
Successful treatment of atypical mycobacterial meningitis by fluoroquinolone.
Topics: Administration, Oral; Adult; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Antitubercular Agents; Cycloserine; Ethambutol; Humans; Injections, Spinal; Isoniazid; Male; Meningitis; Mycobacterium avium Complex; Mycobacterium Infections, Nontuberculous; Ofloxacin; Polymerase Chain Reaction; Rifampin; Streptomycin | 1996 |
Multidrug-resistance to dapsone, rifampicin, and ofloxacin in Mycobacterium leprae.
Topics: Adult; Anti-Infective Agents; Dapsone; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Mycobacterium leprae; Ofloxacin; Rifampin | 1997 |
Experimental evaluation of possible new short-term drug regimens for treatment of multibacillary leprosy.
Topics: Animals; Clarithromycin; Drug Therapy, Combination; Leprostatic Agents; Leprosy; Mice; Mice, Nude; Mycobacterium leprae; Ofloxacin; Rifampin | 1997 |
Oral treatment of Staphylococcus spp. infected orthopaedic implants with fusidic acid or ofloxacin in combination with rifampicin.
Topics: Administration, Oral; Adult; Aged; Drug Therapy, Combination; Female; Fusidic Acid; Humans; Male; Middle Aged; Ofloxacin; Orthopedic Fixation Devices; Rifampin; Staphylococcal Infections | 1997 |
In vitro susceptibility of penicillin-resistant Streptococcus pneumoniae to levofloxacin, selection of resistant mutants, and time-kill synergy studies of levofloxacin combined with vancomycin, teicoplanin, fusidic acid, and rifampin.
Topics: Anti-Bacterial Agents; Drug Synergism; Drug Therapy, Combination; Fusidic Acid; Levofloxacin; Mutation; Ofloxacin; Penicillin Resistance; Rifampin; Streptococcus pneumoniae; Teicoplanin; Vancomycin | 1996 |
Efficacies of ofloxacin, rifampin, and clindamycin in treatment of Staphylococcus aureus abscesses and correlation with results of an in vitro assay of intracellular bacterial killing.
Topics: Abscess; Animals; Anti-Infective Agents; Antibiotics, Antitubercular; Clindamycin; Microbial Sensitivity Tests; Models, Biological; Ofloxacin; Rabbits; Rats; Rifampin; Staphylococcal Infections; Staphylococcus aureus | 1997 |
beta-Galactosidase reporter system in mycobacteria and its application in rapid antimycobacterial drug screening.
Topics: Anti-Bacterial Agents; Antitubercular Agents; beta-Galactosidase; Escherichia coli; Genes, Reporter; Isoniazid; Kinetics; Microbial Sensitivity Tests; Mycobacterium; Ofloxacin; Plasmids; Pyrazinamide; Recombinant Proteins; Rifampin; Streptomycin | 1997 |
Rate of decline in bacterial index in leprosy; observations after three different chemotherapeutic interventions.
Topics: Anti-Infective Agents; Communicable Disease Control; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy, Borderline; Leprosy, Lepromatous; Ofloxacin; Rifampin; Skin; World Health Organization | 1997 |
Legionella jordanis pneumonia unresponsive to fluoroquinolones in a non-immunocompromised host.
Topics: Aged; Anti-Infective Agents; Ceftriaxone; Drug Therapy, Combination; Erythromycin; Humans; Immunocompetence; Legionella; Legionellosis; Male; Ofloxacin; Pneumonia, Bacterial; Rifampin | 1997 |
Effect of levofloxacin, erythromycin or rifampicin pretreatment on growth of Legionella pneumophila in human monocytes.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Erythromycin; Humans; Legionella pneumophila; Levofloxacin; Microbial Sensitivity Tests; Monocytes; Ofloxacin; Opsonin Proteins; Rifampin | 1997 |
Antimicrobial susceptibility of viridans group streptococci.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefazolin; Ceftriaxone; Clindamycin; Drug Resistance, Microbial; Gentamicins; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Rifampin; Streptococcal Infections; Streptococcus; Thienamycins; Vancomycin; Virginiamycin | 1997 |
[High prevalence of leprosy in the Federated States of Micronesia and special project for the elimination].
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Child; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Micronesia; Minocycline; Ofloxacin; Rifampin | 1997 |
Spinal abscess and spondylitis due to actinomycosis.
Topics: Abscess; Actinomycosis; Adult; Anti-Infective Agents; Drug Combinations; Female; Humans; Magnetic Resonance Imaging; Ofloxacin; Rifampin; Spinal Diseases; Spine; Spondylitis | 1998 |
Relapse (reactivation) in borderline tuberculoid (BT) leprosy.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Dapsone; Drug Monitoring; Granuloma; Histiocytes; Humans; Leprostatic Agents; Leprosy, Borderline; Leprosy, Tuberculoid; Lymphocytes; Male; Minocycline; Ofloxacin; Recurrence; Rifampin | 1998 |
[New WHO recommendations for the treatment of leprosy].
Topics: Clofazimine; Dapsone; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Minocycline; Mycobacterium leprae; Ofloxacin; Rifampin; Skin | 1997 |
In vitro anti-staphylococcal activity of heparinized biomaterials bonded with combinations of rifampicin.
Topics: Anti-Bacterial Agents; Biocompatible Materials; Cefuroxime; Collagen; Fusidic Acid; Ofloxacin; Rifampin; Staphylococcus epidermidis; Vancomycin | 1998 |
Relapse of multibacillary leprosy after rifampin and ofloxacin treatment for 28 days; a case report.
Topics: Adult; Drug Therapy, Combination; Humans; Leprosy; Male; Ofloxacin; Recurrence; Rifampin | 1998 |
[Endogenous infectious endophthalmitis].
Topics: Aged; Amphotericin B; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Endophthalmitis; Flucytosine; Humans; Male; Middle Aged; Ofloxacin; Oxacillin; Rifampin; Staphylococcal Infections; Vitrectomy | 1998 |
Pro- and anti-oxidant effects of some antileprotic drugs in vitro and their influence on super oxide dismutase activity.
Topics: Antioxidants; Clofazimine; Dapsone; Dianisidine; Leprostatic Agents; Ofloxacin; Reactive Oxygen Species; Riboflavin; Rifampin; Superoxide Dismutase; Superoxides | 1998 |
Antibacterial effects of levofloxacin, erythromycin, and rifampin in a human monocyte system against Legionella pneumophila.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Antibiotics, Antitubercular; Colony Count, Microbial; Drug Therapy, Combination; Erythromycin; Humans; In Vitro Techniques; Legionella pneumophila; Levofloxacin; Monocytes; Ofloxacin; Rifampin | 1998 |
Relapse of multibacillary leprosy after treatment with daily rifampin plus ofloxacin for four weeks.
Topics: Anti-Infective Agents; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Ofloxacin; Recurrence; Rifampin | 1998 |
Atypical mycobacterium infection with dermatological manifestation in a renal transplant recipient.
Topics: Clarithromycin; Drug Therapy, Combination; Ethambutol; Foot; Humans; Kidney Transplantation; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ofloxacin; Postoperative Complications; Rifampin; Skin Diseases, Bacterial | 1999 |
Report of workshop on chemotherapy.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Minocycline; Ofloxacin; Rifampin; World Health Organization | 1998 |
Intensified prophylaxis of febrile neutropenia with ofloxacin plus rifampin during severe short-duration neutropenia in patients with lymphoma.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Carmustine; Cyclophosphamide; Etoposide; Female; Fever; Hodgkin Disease; Humans; Length of Stay; Lymphoma; Male; Middle Aged; Neutropenia; Ofloxacin; Opportunistic Infections; Rifampin; Salvage Therapy | 1999 |
Single-dose treatment for paucibacillary leprosy; feasibility of long-term follow up.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Community Health Workers; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Minocycline; Mycobacterium leprae; Ofloxacin; Rifampin | 1999 |
Single-dose treatment for paucibacillary leprosy; clinical problems and management.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Infective Agents; Child; Clofazimine; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Minocycline; Mycobacterium leprae; Ofloxacin; Prednisolone; Rifampin; Secondary Prevention | 1999 |
Single-dose treatment for paucibacillary leprosy; field implications.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cohort Studies; Confidence Intervals; Drug Therapy, Combination; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy; Minocycline; Mycobacterium leprae; Ofloxacin; Rifampin; Secondary Prevention | 1999 |
Brucella canis endocarditis: case report.
Topics: Brucella; Brucellosis; Doxycycline; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Humans; Male; Middle Aged; Ofloxacin; Rifampin | 1999 |
A recurrent case of BT leprosy with widely spread skin lesions showing a histopathology of indeterminate group after 4.5-years irregular treatment, Bangladesh.
Topics: Adult; Bangladesh; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy, Borderline; Leprosy, Tuberculoid; Male; Ofloxacin; Recurrence; Rifampin; Skin; Time Factors; Treatment Outcome; Treatment Refusal | 1999 |
A case of reconstruction of saddle nose deformity in leprosy.
Topics: Adult; Bone Transplantation; Communicable Disease Control; Drug Therapy, Combination; Female; Health Education; Humans; Leprostatic Agents; Leprosy, Lepromatous; Nose Deformities, Acquired; Ofloxacin; Plastic Surgery Procedures; Rhinoplasty; Rifampin; Treatment Outcome | 1999 |
Histopathological activity in paucibacillary leprosy patients after ROM therapy.
Topics: Adolescent; Adult; Child; Child, Preschool; Female; Granuloma; Humans; Leprosy, Lepromatous; Male; Minocycline; Ofloxacin; Rifampin; Skin | 1999 |
Elimination of leprosy in the federated states of micronesia by intensive case finding, treatment with WHO/MDT and administration of chemoprophylaxis.
Topics: Adolescent; Adult; Chemoprevention; Humans; Leprostatic Agents; Leprosy; Micronesia; Minocycline; Ofloxacin; Rifampin; World Health Organization | 1999 |
Population screening and mass chemoprophylaxis in Kiribati.
Topics: Adolescent; Chemoprevention; Child; Child, Preschool; Communicable Disease Control; Humans; Leprostatic Agents; Leprosy; Mass Screening; Micronesia; Minocycline; Ofloxacin; Patient Care Team; Rifampin | 1999 |
Population screening and chemoprophylaxis for household contacts of leprosy patients in the Republic of the Marshall Islands.
Topics: Chemoprevention; Contact Tracing; Drug Therapy, Combination; Leprostatic Agents; Leprosy; Mass Screening; Micronesia; Minocycline; Ofloxacin; Prevalence; Rifampin | 1999 |
Comparative in vitro activity of vancomycin and levofloxacin in combination with rifampin against planktonic versus sessile cells of Staphylococcus epidermidis.
Topics: Drug Therapy, Combination; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Rifampin; Staphylococcus epidermidis; Vancomycin | 2000 |
Activities of antimicrobial agents against intracellular pneumococci.
Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Fluoroquinolones; Gentamicins; Humans; Ketolides; Levofloxacin; Macrolides; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Penicillin G; Quinolines; Rifampin; Streptococcus pneumoniae; Tumor Cells, Cultured | 2000 |
Effect of treatment on PCR positivity in multibacillary leprosy patients treated with conventional and newer drugs ofloxacin and minocycline.
Topics: Adenosine Triphosphate; Biopsy; Clofazimine; Dapsone; DNA, Bacterial; Drug Evaluation; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Minocycline; Mycobacterium leprae; Ofloxacin; Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Treatment Outcome | 1999 |
Evaluation of Etest for susceptibility testing of Mycobacterium tuberculosis.
Topics: Agar; Anti-Infective Agents; Antitubercular Agents; Ciprofloxacin; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Streptomycin | 2000 |
Recurrent penicillin-resistant pneumococcal sepsis after matched unrelated donor (MUD) transplantation for refractory T cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bone Marrow Transplantation; Carmustine; Cefotaxime; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Cytomegalovirus Infections; Doxorubicin; Drug Therapy, Combination; Etoposide; Humans; Idarubicin; Immunocompromised Host; Immunosuppressive Agents; Levofloxacin; Lymphoma, T-Cell; Male; Melphalan; Ofloxacin; Penicillin Resistance; Pneumococcal Infections; Prednisone; Recurrence; Rifampin; Splenectomy; Streptococcus pneumoniae; Transplantation Conditioning; Vincristine | 2000 |
Bioluminescent Mycobacterium aurum expressing firefly luciferase for rapid and high throughput screening of antimycobacterial drugs in vitro and in infected macrophages.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antitubercular Agents; Cell Line; Coleoptera; Fluoroquinolones; Genes, Reporter; Luciferases; Luminescent Measurements; Macrophages; Mice; Microbial Sensitivity Tests; Mycobacterium; Ofloxacin; Recombinant Proteins; Rifampin; Streptomycin; Transfection | 2000 |
Efficacy of rifampin-levofloxacin as a prophylactic agent in preventing Staphylococcus epidermidis graft infection.
Topics: Animals; Blood Vessel Prosthesis; Humans; Levofloxacin; Male; Methicillin Resistance; Microbial Sensitivity Tests; Ofloxacin; Prosthesis-Related Infections; Rats; Rats, Wistar; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis | 2000 |
Leprosy chemoprophylaxis in Micronesia.
Topics: Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Incidence; Leprostatic Agents; Leprosy; Male; Mass Screening; Micronesia; Minocycline; Ofloxacin; Rifampin; Treatment Outcome | 2000 |
Field trials of a single dose of the combination rifampicin-ofloxacin-minocycline (ROM) for the treatment of paucibacillary leprosy.
Topics: Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; India; Leprostatic Agents; Leprosy; Minocycline; Ofloxacin; Prognosis; Rifampin; Treatment Outcome | 2000 |
Single lesion paucibacillary leprosy: baseline profile of the Brazilian Multicenter Cohort Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Biopsy; Brazil; Child; Cohort Studies; Drug Therapy, Combination; Educational Status; Female; Humans; Leprostatic Agents; Leprosy, Lepromatous; Male; Middle Aged; Minocycline; Mycobacterium leprae; Ofloxacin; Patient Selection; Rifampin | 2000 |
Single-dose treatment for single lesion leprosy; histopathological observations.
Topics: Anti-Infective Agents; Drug Therapy, Combination; Granuloma; Humans; Leprostatic Agents; Leprosy; Minocycline; Ofloxacin; Rifampin; Tetracycline | 2000 |
A whole blood bactericidal assay for tuberculosis.
Topics: Anti-Infective Agents; Antitubercular Agents; Aza Compounds; Blood; Blood Bactericidal Activity; Culture Media; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Quinolines; Rifampin | 2001 |
Double-edged sword of chemosensitizer: increase of multidrug resistance protein (MRP) in leukemic cells by an MRP inhibitor probenecid.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Blotting, Western; Cell Division; Cell Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Enzyme Inhibitors; Erythromycin; HL-60 Cells; Humans; Leukemia, Myeloid, Acute; Multidrug Resistance-Associated Proteins; Ofloxacin; Probenecid; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; Rifampin; RNA, Messenger; Tumor Cells, Cultured; Uricosuric Agents; Vincristine | 2001 |
A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.
Topics: Animals; Anti-Infective Agents; Antitubercular Agents; Clarithromycin; Clofazimine; Colony Count, Microbial; Dapsone; Drug Resistance, Microbial; Drug Resistance, Multiple; Fluoroquinolones; Humans; Leprostatic Agents; Leprosy; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Mycobacterium leprae; Ofloxacin; Rifampin | 2000 |
Zenker's diverticulum associated with multilevel cervical osteomyelitis.
Topics: Anti-Infective Agents; Antibiotics, Antitubercular; Cervical Vertebrae; Fistula; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Ofloxacin; Osteomyelitis; Rifampin; Spinal Diseases; Suppuration; Tomography, X-Ray Computed; Zenker Diverticulum | 2001 |
Clinical, histopathological and bacteriological investigations in two cases of relapse following ROM treatment.
Topics: Adult; Animals; Drug Therapy, Combination; Female; Humans; Leprostatic Agents; Leprosy; Male; Mice; Middle Aged; Minocycline; Ofloxacin; Recurrence; Rifampin | 2001 |
CPCRA researchers present OI studies at Vancouver.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antitubercular Agents; Candidiasis; Child; Clarithromycin; Clinical Trials as Topic; DNA, Viral; Drug Therapy, Combination; Ethambutol; Female; Fluconazole; Humans; Isoniazid; Molluscum Contagiosum; Molluscum contagiosum virus; Multicenter Studies as Topic; Mycobacterium avium-intracellulare Infection; Ofloxacin; Patient Compliance; Pyrazinamide; Rifampin; Sequence Analysis, DNA; Tuberculosis | 1996 |
The treatment of multidrug-resistant tuberculosis in Turkey.
Topics: Adolescent; Adult; Aged; Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Isoniazid; Logistic Models; Male; Middle Aged; Ofloxacin; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary; Turkey | 2001 |
Comparative in vitro bacteriostatic and bactericidal activity of trovafloxacin, levofloxacin and moxifloxacin against clinical and environmental isolates of Legionella spp.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Fluoroquinolones; Humans; Legionella; Legionellosis; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Rifampin | 2001 |
[Comparison of three antituberculous drugs in serum and cold abscesses of patients with spinal tuberculosis].
Topics: Abscess; Adult; Anti-Infective Agents; Antitubercular Agents; Female; Humans; Isoniazid; Male; Ofloxacin; Rifampin; Tuberculosis, Spinal | 1998 |
Histological resolution and bacterial clearance with pulse ROM therapy in borderline lepromatous leprosy.
Topics: Adolescent; Anti-Infective Agents; Drug Therapy, Combination; Extremities; Female; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy, Borderline; Minocycline; Mycobacterium leprae; Ofloxacin; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Pulse Therapy, Drug; Rifampin; Skin; Treatment Outcome | 2001 |
Multidrug resistant Mycobacterium leprae from patients with leprosy.
Topics: Animals; Anti-Infective Agents; Antibiotics, Antitubercular; Base Sequence; DNA Primers; DNA, Bacterial; Drug Resistance, Microbial; Drug Resistance, Multiple; Genes, Bacterial; Humans; Leprostatic Agents; Leprosy; Mice; Molecular Sequence Data; Mycobacterium leprae; Ofloxacin; Reverse Transcriptase Polymerase Chain Reaction; Rifampin | 2001 |
Molecular detection of rifampin and ofloxacin resistance for patients who experience relapse of multibacillary leprosy.
Topics: Adult; Aged; Antibiotics, Antitubercular; Disease Models, Animal; DNA Gyrase; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Leprosy; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium leprae; Ofloxacin; Plant Proteins; Recurrence; Rifampin | 2002 |
Rifampicin-ofloxacin oral regimen for the treatment of mild to moderate diabetic foot osteomyelitis.
Topics: Administration, Oral; Aged; Anti-Infective Agents; Antibiotics, Antitubercular; Bacterial Infections; Chronic Disease; Diabetic Foot; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Ofloxacin; Osteomyelitis; Rifampin; Treatment Outcome | 2001 |
Pharmacokinetics of antituberculosis medications delivered via percutaneous gastrojejunostomy tube.
Topics: Adult; Aminosalicylic Acid; Antitubercular Agents; Female; Gastrostomy; Humans; Jejunostomy; Levofloxacin; Ofloxacin; Rifampin; Saskatchewan; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2002 |
[Vascular graft infection by Staphylococcus epidermidis: efficacy of various perioperative prophylaxis protocols in an animal model].
Topics: Animals; Blood Vessel Prosthesis Implantation; Cefazolin; Drug Evaluation, Preclinical; Drug Implants; Drug Resistance; Drug Therapy, Combination; Injections, Intraperitoneal; Levofloxacin; Male; Methicillin Resistance; Models, Animal; Ofloxacin; Oxacillin; Premedication; Prostheses and Implants; Prosthesis-Related Infections; Rats; Rats, Wistar; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis; Teicoplanin | 2001 |
Single-dose ROM treatment for multilesion paucibacillary leprosy--further observations.
Topics: Clinical Trials as Topic; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Minocycline; Ofloxacin; Recurrence; Rifampin | 2002 |
Rhodococcus equi: pulmonary cavitation lesion in patient infected with HIV cured by levofloxacin and rifampicin.
Topics: Actinomycetales Infections; Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Drug Therapy, Combination; HIV Infections; Humans; Levofloxacin; Lung Diseases; Male; Ofloxacin; Rhodococcus equi; Rifampin | 2002 |
Bacteriological conversion in twenty urinary tuberculosis patients treated with ofloxacin, rifampin and isoniazid: a 10-year follow-up study.
Topics: Adult; Aged; Anti-Infective Agents, Urinary; Antitubercular Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Treatment Outcome; Tuberculosis; Urinary Tract Infections | 2002 |
[Effect of levofloxacine on cell elements of the lung tissue and on the growth of drug resistant Mycobacteria tuberculosis].
Topics: Animals; Anti-Infective Agents; Antitubercular Agents; Cell Movement; Culture Techniques; Drug Interactions; Drug Resistance, Multiple, Bacterial; Isoniazid; Levofloxacin; Lung; Lymphocytes; Macrophages; Mice; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Rifampin | 2002 |
Relapse rates and a 10-year follow-up of a 6-week quadruple drug regimen for multibacillary leprosy.
Topics: Belgium; Clofazimine; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy; Ofloxacin; Recurrence; Rifampin | 2002 |
Population pharmacokinetics of antituberculous drugs and treatment of Mycobacterium bovis infection in bongo antelope (Tragelaphus eurycerus isaaci).
Topics: Amikacin; Animals; Antelopes; Antitubercular Agents; Area Under Curve; Ethambutol; Female; Isoniazid; Levofloxacin; Male; Mycobacterium bovis; Ofloxacin; Pyrazinamide; Rifampin; Tuberculosis | 2002 |
In vitro sensitivity of Mycobacterium xenopi to five antibiotics.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Ethambutol; Microbial Sensitivity Tests; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Ofloxacin; Rifampin | 2002 |
In vivo susceptibility of Mycobacterium leprae to sitafloxacin (DU-6859a), either singly or in combination with rifampicin analogues.
Topics: Animals; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fluoroquinolones; Leprostatic Agents; Leprosy; Mice; Mice, Inbred BALB C; Mycobacterium leprae; Ofloxacin; Rifampin | 2003 |
Pharmacokinetics of ofloxacin in drug-resistant tuberculosis.
Topics: Adult; Anti-Infective Agents; Antitubercular Agents; Area Under Curve; Chromatography, High Pressure Liquid; Drug Therapy, Combination; Humans; Middle Aged; Ofloxacin; Pyrazinamide; Rifampin; Tuberculosis, Multidrug-Resistant | 2003 |
[A study on the clinical efficacy of a combination regimen with levofloxacin and capreomycin in the treatment of multi-drug resistant pulmonary tuberculosis].
Topics: Adolescent; Adult; Antitubercular Agents; Capreomycin; Drug Therapy, Combination; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 2003 |
In situ type 1 cytokine gene expression and mechanisms associated with early leprosy progression.
Topics: Adolescent; Adult; Antibodies, Bacterial; Biopsy; Child; Cohort Studies; Cytokines; Female; Gene Expression Regulation, Bacterial; Humans; Leprosy; Male; Minocycline; Mycobacterium leprae; Ofloxacin; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; Rifampin; RNA, Messenger; RNA, Viral; Th1 Cells | 2003 |
Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Proteins; Blotting, Southern; Carbon-Oxygen Ligases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Microbial Sensitivity Tests; Ofloxacin; Oxacillin; Penicillins; Pennsylvania; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Rifampin; Staphylococcal Infections; Vancomycin; Vancomycin Resistance | 2004 |
Legionella pneumonia: infection during immunosuppressive therapy for idiopathic pulmonary hemosiderosis.
Topics: Child; Drug Therapy, Combination; Female; Follow-Up Studies; Hemosiderosis; Humans; Immunosuppressive Agents; Infusions, Intravenous; Legionnaires' Disease; Lung Diseases; Ofloxacin; Opportunistic Infections; Radiography, Thoracic; Rifampin; Risk Assessment; Treatment Outcome | 2004 |
[Antibiotics-resistance pattern and genetic type of Streptococcus pneumoniae isolated from children in Hangzhou].
Topics: Anti-Bacterial Agents; Cefotaxime; Child, Preschool; China; Chloramphenicol; Drug Resistance, Bacterial; Erythromycin; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Ofloxacin; Penicillins; Pneumococcal Infections; Respiratory Tract Infections; Rifampin; Streptococcus pneumoniae; Tetracycline; Trimethoprim | 2004 |
A rare variant of erythema nodosum leprosum: a case report.
Topics: Abscess; Adult; Drug Resistance, Bacterial; Drug Therapy, Combination; Erythema Nodosum; Humans; Leprostatic Agents; Leprosy, Lepromatous; Macrophages; Male; Melanins; Minocycline; Mycobacterium tuberculosis; Neutrophils; Ofloxacin; Rifampin; Tumor Necrosis Factor-alpha; Vasculitis | 2003 |
Efficacy of oral levofloxacin and dirithromycin alone and in combination with rifampicin in the treatment of experimental murine Brucella abortus infection.
Topics: Animals; Anti-Bacterial Agents; Brucella abortus; Brucellosis; Drug Therapy, Combination; Erythromycin; Levofloxacin; Male; Mice; Ofloxacin; Rifampin; Treatment Outcome | 2004 |
Salvage of a prosthetic knee joint infected with resistant pneumococcus. A case report.
Topics: Aged; Anti-Infective Agents; Arthritis, Infectious; Arthroplasty, Replacement, Knee; Azithromycin; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Male; Ofloxacin; Pneumococcal Infections; Prosthesis-Related Infections; Rifampin; Vancomycin | 2004 |
[Multi-drug resistant Mycobacterium leprae from patients with leprosy].
Topics: Animals; Base Sequence; Dapsone; DNA Gyrase; DNA-Directed RNA Polymerases; Drug Resistance, Multiple; Humans; Leprostatic Agents; Leprosy; Mutation; Mycobacterium leprae; Ofloxacin; Rifampin | 2004 |
Action of fluoroquinolones and Linezolid on logarithmic- and stationary-phase culture of Mycobacterium tuberculosis.
Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Culture Media; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Hydrogen-Ion Concentration; Levofloxacin; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Oxazolidinones; Quinolines; Rifampin; Structure-Activity Relationship; Time Factors | 2004 |
[Tuberculoma and tuberculous meningeal-radiculitis with paradoxical progression during treatment].
Topics: Aged; Anti-Inflammatory Agents; Antitubercular Agents; Confusion; Disease Progression; Drug Therapy, Combination; Female; Fever; Humans; Immunocompetence; Isoniazid; Magnetic Resonance Imaging; Ofloxacin; Prednisone; Radiculopathy; Rifampin; Spinal Puncture; Tomography, X-Ray Computed; Treatment Outcome; Tuberculoma; Tuberculoma, Intracranial; Tuberculosis, Meningeal | 2005 |
Drug-sensitivity profile of clinical Mycobacterium tuberculosis isolates--a retrospective study from a chest-disease institute in India.
Topics: Adult; Aged; Antitubercular Agents; Ciprofloxacin; Drug Resistance, Bacterial; Female; Humans; India; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Retrospective Studies; Rifampin; Sputum; Treatment Failure; Tuberculosis, Pulmonary | 2005 |
Treatment outcome of multidrug-resistant tuberculosis among Vietnamese immigrants.
Topics: Capreomycin; Cycloserine; Drug Therapy, Combination; Emigration and Immigration; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Male; Middle Aged; Ofloxacin; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Multidrug-Resistant; Vietnam | 2005 |
Chemotherapy of leprosy.
Topics: Anti-Bacterial Agents; Clofazimine; Dapsone; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; HIV Infections; Humans; Hypersensitivity; India; Leprosy; Minocycline; Nausea; Ofloxacin; Rifampin; Secondary Prevention; Tuberculosis; World Health Organization | 2004 |
An analysis of a community-acquired pathogen in a Kentucky community: methicillin-resistant Staphylococcus aureus.
Topics: Adult; Anti-Bacterial Agents; Cefazolin; Clindamycin; Community-Acquired Infections; Erythromycin; Female; Humans; Kentucky; Levofloxacin; Male; Methicillin; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Ofloxacin; Oxacillin; Rifampin; Risk Factors; Staphylococcal Infections; Staphylococcus aureus; Sulfamethoxazole; Tetracycline; Trimethoprim; Vancomycin | 2005 |
Mixed cryoglobulinemia with renal failure, cutaneous vasculitis and peritonitis due to Brucella melitensis.
Topics: Anti-Bacterial Agents; Ascitic Fluid; Brucella melitensis; Brucellosis; Cryoglobulinemia; Doxycycline; Humans; Male; Middle Aged; Ofloxacin; Peritonitis; Renal Insufficiency; Rifampin; Vasculitis, Leukocytoclastic, Cutaneous | 2005 |
[Pelvic pseudotumoral actinomycosis with multisegmental lumbosacral root failure. A case report].
Topics: Actinomycosis; Adult; Female; Humans; Lumbar Vertebrae; Ofloxacin; Ovarian Diseases; Pelvic Infection; Rifampin; Sacrum | 2005 |
[In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis].
Topics: Acetamides; Anti-Bacterial Agents; Aza Compounds; Clindamycin; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Fluoroquinolones; Levofloxacin; Linezolid; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Oxazolidinones; Quinolines; Rifampin; Staphylococcus aureus; Staphylococcus epidermidis | 2005 |
Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Antitubercular Agents; Ciprofloxacin; Clarithromycin; Drug Synergism; Ethambutol; Fluoroquinolones; Humans; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Minocycline; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis | 2005 |
Quantitative determinations of levofloxacin and rifampicin in pharmaceutical and urine samples using nuclear magnetic resonance spectroscopy.
Topics: Calibration; Dimethyl Sulfoxide; Dosage Forms; Humans; Levofloxacin; Magnetic Resonance Spectroscopy; Maleates; Models, Molecular; Molecular Conformation; Ofloxacin; Rifampin; Sensitivity and Specificity | 2005 |
Bacillary angiomatosis associated with pseudoepitheliomatous hyperplasia.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Angiomatosis, Bacillary; Anti-Bacterial Agents; Bartonella; DNA, Bacterial; Doxycycline; Drug Therapy, Combination; Epidermis; Fingers; Humans; Hyperplasia; Immunocompromised Host; Lymph Nodes; Male; Middle Aged; Ofloxacin; Rifampin; Treatment Outcome | 2006 |
Comparative study of antimicrobial release kinetics from polymethylmethacrylate.
Topics: Acetamides; Anti-Bacterial Agents; Area Under Curve; Cefazolin; Ciprofloxacin; Fluoroquinolones; Gatifloxacin; Humans; Levofloxacin; Linezolid; Ofloxacin; Oxazolidinones; Polymethyl Methacrylate; Rifampin | 2006 |
Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome.
Topics: Adult; Antibiotics, Antitubercular; Ciprofloxacin; Clarithromycin; Cycloserine; Ethambutol; Ethionamide; Female; Humans; Israel; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Ofloxacin; Prognosis; Rifampin | 2006 |
In-vitro activity of quinupristin/dalfopristin, levofloxacin and moxifloxacin against fusidic acid and rifampicin-resistant strains of methicillin-resistant Staphylococcus aureus (MRSA) from Malaysian hospitals.
Topics: Anti-Bacterial Agents; Aza Compounds; Disease Susceptibility; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Fusidic Acid; Humans; In Vitro Techniques; Levofloxacin; Malaysia; Methicillin Resistance; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Rifampin; Staphylococcus aureus; Virginiamycin | 2005 |
Treatment of acute post-surgical infection of joint arthroplasty.
Topics: Acute Disease; Aged; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Bacterial Infections; Debridement; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Levofloxacin; Male; Ofloxacin; Prosthesis-Related Infections; Rifampin; Treatment Outcome | 2006 |
Corynebacterium pseudotuberculosis necrotizing lymphadenitis in a twelve-year-old patient.
Topics: Adolescent; Anti-Bacterial Agents; Antibiotics, Antitubercular; Corynebacterium pseudotuberculosis; Female; Histiocytic Necrotizing Lymphadenitis; Humans; Ofloxacin; Rifampin | 2006 |
Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cloxacillin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Foreign-Body Reaction; Humans; Levofloxacin; Linezolid; Male; Methicillin; Microbial Sensitivity Tests; Ofloxacin; Oxazolidinones; Rats; Rats, Wistar; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2006 |
[Basic evaluation for new antimicrobial susceptibility testing of Mycobacterium leprae by bioluminescence assay (ATP method)].
Topics: Animals; Clarithromycin; Clofazimine; Drug Resistance, Bacterial; Leprostatic Agents; Leprosy; Luciferases; Luminescent Agents; Mice; Mice, Nude; Microbial Sensitivity Tests; Mycobacterium leprae; Ofloxacin; Rifampin | 2006 |
Conservative treatment of staphylococcal prosthetic joint infections in elderly patients.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Chi-Square Distribution; Debridement; Drug Administration Schedule; Female; Hip Prosthesis; Humans; Joint Prosthesis; Knee Prosthesis; Levofloxacin; Male; Methicillin Resistance; Ofloxacin; Prosthesis-Related Infections; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Time Factors; Treatment Failure; Treatment Outcome | 2006 |
In vitro activity of linezolid in combination with doxycycline, fosfomycin, levofloxacin, rifampicin and vancomycin against methicillin-susceptible Staphylococcus aureus.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Doxycycline; Drug Therapy, Combination; Enzyme Inhibitors; Fosfomycin; Humans; In Vitro Techniques; Levofloxacin; Linezolid; Microbial Sensitivity Tests; Ofloxacin; Oxazolidinones; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2006 |
Lateral gene transfer in vitro in the intracellular pathogen Chlamydia trachomatis.
Topics: Anti-Bacterial Agents; Chlamydia trachomatis; Drug Resistance, Bacterial; Gene Expression Regulation; Gene Transfer, Horizontal; Genes, Bacterial; Genetic Complementation Test; HeLa Cells; Humans; Lincomycin; Microbial Sensitivity Tests; Microscopy, Phase-Contrast; Mutation; Ofloxacin; Rifampin; Trimethoprim | 2007 |
Evaluation of an intracellular pharmacokinetic in vitro infection model as a tool to assess tuberculosis therapy.
Topics: Antitubercular Agents; Cell Line; Half-Life; Humans; Isoniazid; Levofloxacin; Mycobacterium tuberculosis; Ofloxacin; Rifampin | 2007 |
[Musculoskeletal adverse effects of levofloxacin].
Topics: Anti-Bacterial Agents; Arthralgia; Arthritis; Arthritis, Infectious; Arthroplasty, Replacement, Knee; Atorvastatin; Combined Modality Therapy; Debridement; Diagnosis, Differential; Doxycycline; Drug Interactions; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Levofloxacin; Middle Aged; Ofloxacin; Postoperative Complications; Prosthesis-Related Infections; Pyrroles; Recurrence; Reoperation; Rifampin; Thyroiditis, Autoimmune; Thyroxine; Trimethoprim, Sulfamethoxazole Drug Combination | 2006 |
[In-vitro and in-vivo activities of moxifloxacin and garenoxacin against Mycobacterium leprae].
Topics: Animals; Anti-Infective Agents; Aza Compounds; Drug Resistance, Bacterial; Female; Fluoroquinolones; Gatifloxacin; Leprostatic Agents; Levofloxacin; Mice; Mice, Inbred BALB C; Mice, Nude; Moxifloxacin; Mycobacterium leprae; Ofloxacin; Quinolines; Rifampin | 2007 |
Efficacy of a novel rifamycin derivative, ABI-0043, against Staphylococcus aureus in an experimental model of foreign-body infection.
Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Disease Models, Animal; Drug Therapy, Combination; Foreign-Body Reaction; Guinea Pigs; Injections, Intraperitoneal; Levofloxacin; Male; Microbial Sensitivity Tests; Molecular Structure; Ofloxacin; Rifampin; Rifamycins; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 2007 |
Methicillin-sensitive Staphylococcus aureus tricuspid valve endocarditis with annular abscess cured with oral levofloxacin and rifampicin.
Topics: Abscess; Adult; Anti-Bacterial Agents; Cloxacillin; Endocarditis, Bacterial; Fever; Humans; Levofloxacin; Male; Methicillin Resistance; Ofloxacin; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Tricuspid Valve | 2007 |
Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China.
Topics: Antitubercular Agents; Bacterial Proteins; China; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Ofloxacin; Pentosyltransferases; Rifampin; Tuberculosis | 2007 |
[Long-term follow-up of ofloxacin-combined therapy for leprosy patients].
Topics: Aged; Anti-Bacterial Agents; Clofazimine; Cystamine; Drug Therapy, Combination; Follow-Up Studies; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Minocycline; Ofloxacin; Rifampin; Time Factors; Treatment Outcome | 2007 |
Persistence of peri-neural granulomas after successful treatment of leprosy.
Topics: Diagnosis, Differential; Drug Therapy, Combination; Granuloma; Humans; Leprostatic Agents; Leprosy; Male; Middle Aged; Ofloxacin; Rifampin; Skin Diseases | 2007 |
Mycobacterium leprae DNA associated with type 1 reactions in single lesion paucibacillary leprosy treated with single dose rifampin, ofloxacin, and minocycline.
Topics: Adolescent; Adult; Aging; Cohort Studies; DNA, Bacterial; Erythema Nodosum; Female; Humans; Leprosy; Male; Middle Aged; Minocycline; Mycobacterium leprae; Ofloxacin; Polymerase Chain Reaction; Rifampin; Risk Factors; Time Factors | 2007 |
Interstrain gene transfer in Chlamydia trachomatis in vitro: mechanism and significance.
Topics: Chlamydia trachomatis; Drug Resistance, Bacterial; Gene Transfer, Horizontal; Genes, Bacterial; Models, Genetic; Molecular Sequence Data; Ofloxacin; Polymorphism, Genetic; Rifampin; Sequence Analysis, DNA; Species Specificity | 2008 |
Simultaneous determination of rifampicin and levofloxacin concentrations in catheter segments from a mouse model of a device-related infection by liquid chromatography/electrospray ionization tandem mass spectrometry.
Topics: Animals; Anti-Bacterial Agents; Catheters, Indwelling; Chromatography, High Pressure Liquid; Disease Models, Animal; Levofloxacin; Mice; Mice, Inbred BALB C; Ofloxacin; Rifampin; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Staphylococcus aureus | 2008 |
Kytococcus schroeteri: a probably underdiagnosed pathogen involved in prosthetic valve endocarditis.
Topics: Actinomycetales; Actinomycetales Infections; Adult; Aortic Valve Insufficiency; DNA, Bacterial; Drug Administration Schedule; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Echocardiography, Transesophageal; Endocarditis, Bacterial; Female; Gentamicins; Heart Valve Prosthesis; Humans; Microbial Sensitivity Tests; Ofloxacin; Polymerase Chain Reaction; Rifampin; Vancomycin | 2008 |
Emergence of levofloxacin-non-susceptible Streptococcus pneumoniae and treatment for multidrug-resistant tuberculosis in children in South Africa: a cohort observational surveillance study.
Topics: Adolescent; Anti-Bacterial Agents; Antitubercular Agents; Child; Child, Preschool; Cross Infection; Cross-Sectional Studies; Drug Resistance, Bacterial; Female; Humans; Infant; Levofloxacin; Male; Ofloxacin; Pneumococcal Infections; Population Surveillance; Rifampin; Risk Factors; South Africa; Statistics, Nonparametric; Streptococcus pneumoniae; Tuberculosis, Multidrug-Resistant; World Health Organization | 2008 |
Tuberculosis drug resistance comes full circle.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Drug Resistance, Bacterial; Humans; Ofloxacin; Pneumococcal Infections; Rifampin; South Africa; Tuberculosis, Multidrug-Resistant; World Health Organization | 2008 |
Levofloxacin plus rifampicin conservative treatment of 25 early staphylococcal infections of osteosynthetic devices for rigid internal fixation.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Coagulase; Drug Therapy, Combination; Female; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Orthopedic Fixation Devices; Prosthesis-Related Infections; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2008 |
Antagonistic effect of rifampin on the efficacy of high-dose levofloxacin in staphylococcal experimental foreign-body infection.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Dose-Response Relationship, Drug; Drug Interactions; Foreign Bodies; Levofloxacin; Male; Ofloxacin; Prosthesis-Related Infections; Rats; Rats, Wistar; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 2008 |
[Treatment of osteoarticular infections with clindamycin in adults].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bone Diseases; Clindamycin; Diarrhea; Drug Therapy, Combination; Drug Tolerance; Female; Humans; Joint Diseases; Male; Middle Aged; Ofloxacin; Osteitis; Prosthesis Implantation; Retrospective Studies; Rifampin; Staphylococcal Infections; Surgical Procedures, Operative; Teicoplanin | 2008 |
Type I reaction in a borderline leprosy case successfully treated with multidrug therapy and ofloxacin.
Topics: Anti-Bacterial Agents; Clofazimine; Dapsone; Drug Therapy, Combination; Glucocorticoids; Humans; Leprostatic Agents; Leprosy, Borderline; Male; Middle Aged; Ofloxacin; Prednisone; Rifampin | 2008 |
Simultaneous quantification of linezolid, rifampicin, levofloxacin, and moxifloxacin in human plasma using high-performance liquid chromatography with UV.
Topics: Acetamides; Anti-Bacterial Agents; Antibiotics, Antitubercular; Aza Compounds; Calibration; Chromatography, High Pressure Liquid; Fluoroquinolones; Humans; Levofloxacin; Linezolid; Moxifloxacin; Ofloxacin; Oxazolidinones; Quality Control; Quinolines; Reference Standards; Reproducibility of Results; Rifampin; Solutions; Solvents; Spectrophotometry, Ultraviolet | 2009 |
Treatment of pyogenic (non-tuberculous) spondylodiscitis with tailored high-dose levofloxacin plus rifampicin.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Discitis; Drug Monitoring; Female; Follow-Up Studies; Gram-Positive Bacterial Infections; Humans; Levofloxacin; Male; Middle Aged; Ofloxacin; Rifampin; Treatment Outcome; Young Adult | 2009 |
Bactericidal activity of the combination of levofloxacin with rifampin in experimental prosthetic knee infection in rabbits due to methicillin-susceptible Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Disease Models, Animal; Drug Therapy, Combination; Humans; Knee Prosthesis; Levofloxacin; Methicillin; Microbial Sensitivity Tests; Ofloxacin; Prosthesis-Related Infections; Rabbits; Rifampin; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome | 2009 |
[Etiological analysis of ocular non-viral microbial isolates in children and their antibiotics susceptibility in vitro].
Topics: Adolescent; Anti-Infective Agents; Bacteria; Child; Child, Preschool; Drug Resistance, Microbial; Eye Infections; Female; Fluconazole; Humans; Infant; Infant, Newborn; Levofloxacin; Male; Microbial Sensitivity Tests; Mitosporic Fungi; Ofloxacin; Retrospective Studies; Rifampin | 2009 |
Granuloma annulare treated with rifampin, ofloxacin, and minocycline combination therapy.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Therapy, Combination; Female; Granuloma Annulare; Humans; Male; Middle Aged; Minocycline; Ofloxacin; Rifampin | 2009 |
[Buruli ulcer involving the head: outcomes and therapeutic aspects in 8 cases observed at the University Hospital Center in Abidjan, Cote d'Ivoire].
Topics: Adolescent; Anti-Bacterial Agents; Anticoagulants; Buruli Ulcer; Child; Child, Preschool; Cote d'Ivoire; Enoxaparin; Eye Infections, Bacterial; Face; Female; Humans; Male; Ofloxacin; Rifampin; Severity of Illness Index; Soft Tissue Infections; Young Adult | 2008 |
Urinary Mycobacterium szulgai infection in an immunocompetent patient.
Topics: Antitubercular Agents; Drug Therapy, Combination; Female; Humans; Immunocompetence; Isoniazid; Levofloxacin; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Ofloxacin; Rifampin; Urinary Tract Infections | 2009 |
Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
Topics: Antitubercular Agents; Bacteriological Techniques; Colony Count, Microbial; Drug Resistance, Multiple, Bacterial; Ethionamide; Extensively Drug-Resistant Tuberculosis; Female; Humans; India; Isoniazid; Kanamycin; Male; Microscopy, Fluorescence; Mycobacterium tuberculosis; Ofloxacin; Population Surveillance; Prevalence; Rifampin; Sputum; Tuberculosis, Multidrug-Resistant | 2009 |
Thin-layer agar for detection of resistance to rifampicin, ofloxacin and kanamycin in Mycobacterium tuberculosis isolates.
Topics: Agar; Anti-Bacterial Agents; Antitubercular Agents; Bacteriological Techniques; Drug Resistance, Bacterial; Humans; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Sensitivity and Specificity | 2009 |
Pyrosequencing for rapid detection of Mycobacterium tuberculosis resistance to rifampin, isoniazid, and fluoroquinolones.
Topics: Antitubercular Agents; Bacterial Proteins; Drug Resistance, Bacterial; Fluoroquinolones; Genotype; Humans; Isoniazid; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Ofloxacin; Phenotype; Rifampin; Sequence Analysis, DNA; Time Factors | 2009 |
[Urinary pneumococcal or Legionella antigen detection tests and low-spectrum antibiotic therapy for community-acquired pneumonia].
Topics: Aged; Aged, 80 and over; Amoxicillin; Anti-Bacterial Agents; Antigens, Bacterial; Cohort Studies; Community-Acquired Infections; Comorbidity; Erythromycin; Female; France; Hospital Mortality; Hospitals, University; Humans; Legionella; Legionnaires' Disease; Lung Diseases, Fungal; Male; Middle Aged; Ofloxacin; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Rifampin; Severity of Illness Index; Streptococcus pneumoniae; Treatment Outcome | 2010 |
In vitro activities of DC-159a, a novel fluoroquinolone, against Mycobacterium species.
Topics: Aminopyridines; Antitubercular Agents; Aza Compounds; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; In Vitro Techniques; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium; Mycobacterium avium Complex; Mycobacterium chelonae; Mycobacterium fortuitum; Mycobacterium Infections; Mycobacterium kansasii; Mycobacterium tuberculosis; Nontuberculous Mycobacteria; Ofloxacin; Quinolines; Rifampin; Species Specificity | 2010 |
A survey of prescribing pattern for osteoarticular tuberculosis: orthopaedic surgeons' and infectious disease experts' perspective.
Topics: Antitubercular Agents; Congresses as Topic; Ethambutol; Humans; Infectious Disease Medicine; Isoniazid; Ofloxacin; Orthopedics; Practice Patterns, Physicians'; Pyrazinamide; Rifampin; Streptomycin; Surveys and Questionnaires; Tuberculosis, Osteoarticular | 2009 |
Simultaneous determination of isoniazid, rifampicin, levofloxacin in mouse tissues and plasma by high performance liquid chromatography-tandem mass spectrometry.
Topics: Animals; Antibiotics, Antitubercular; Brain Chemistry; Chromatography, High Pressure Liquid; Female; Fluoroquinolones; Gatifloxacin; Intestine, Small; Isoniazid; Kidney; Least-Squares Analysis; Levofloxacin; Liver; Lung; Male; Methanol; Mice; Ofloxacin; Reproducibility of Results; Rifampin; Sensitivity and Specificity; Tandem Mass Spectrometry; Tissue Distribution | 2010 |
Clinical-pathological conference: case 3.
Topics: Adult; Dapsone; Diagnosis, Differential; Drug Therapy, Combination; Humans; Immunologic Deficiency Syndromes; Infections; Leishmaniasis; Leprostatic Agents; Leprosy, Multibacillary; Male; Minocycline; Mycobacterium leprae; Ofloxacin; Palate; Prednisone; Rifampin; Strongyloidiasis; Treatment Outcome | 2010 |
[Kingella kingae spondylodiscitis in an adult].
Topics: Adult; Anti-Bacterial Agents; Diagnosis, Differential; Discitis; Drug Therapy, Combination; Epidural Abscess; Humans; Intervertebral Disc Displacement; Kingella kingae; Low Back Pain; Male; Neisseriaceae Infections; Ofloxacin; Rifampin; Spinal Neoplasms | 2011 |
Possible mode of emergence for drug-resistant leprosy is revealed by an analysis of samples from Mexico.
Topics: Bacterial Proteins; Dapsone; DNA Gyrase; DNA, Bacterial; Drug Resistance, Bacterial; Drug Therapy, Combination; Ear, External; Humans; Leprostatic Agents; Leprosy; Mexico; Mutation; Mycobacterium leprae; Ofloxacin; Polymerase Chain Reaction; Prevalence; Rifampin; Sequence Analysis, DNA | 2010 |
Molecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.
Topics: Amikacin; Antitubercular Agents; Bacterial Proteins; Capreomycin; Ciprofloxacin; Ethambutol; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Rifampin | 2011 |
Rifampicin reduces susceptibility to ofloxacin in rifampicin-resistant Mycobacterium tuberculosis through efflux.
Topics: Adrenergic Uptake Inhibitors; Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Bacterial Proteins; Calcium Channel Blockers; Cell Culture Techniques; Disease Models, Animal; DNA-Directed RNA Polymerases; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Reserpine; Reverse Transcriptase Polymerase Chain Reaction; Rifampin; Tuberculosis, Multidrug-Resistant; Verapamil | 2011 |
First case of Legionella pneumophila native valve endocarditis.
Topics: Adult; Aortic Valve; Community-Acquired Infections; Endocarditis, Bacterial; Female; Humans; Immunosuppression Therapy; Legionella pneumophila; Levofloxacin; Ofloxacin; Rifampin | 2011 |
Detection of mutations in folp1, rpoB and gyrA genes of M. leprae by PCR- direct sequencing--a rapid tool for screening drug resistance in leprosy.
Topics: Animals; Bacterial Proteins; Biopsy; Clofazimine; Cross-Sectional Studies; Dapsone; Dihydropteroate Synthase; DNA Gyrase; Drug Resistance, Bacterial; Genetic Predisposition to Disease; Humans; Leprostatic Agents; Leprosy; Mice; Microbial Sensitivity Tests; Mutation; Mycobacterium leprae; Ofloxacin; Polymerase Chain Reaction; Rifampin | 2011 |
Spread of extensively drug-resistant tuberculosis in KwaZulu-Natal province, South Africa.
Topics: Antitubercular Agents; Cross-Sectional Studies; Ethambutol; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Ofloxacin; Rifampin; South Africa; Streptomycin | 2011 |
Fluoroquinolone-resistant tuberculosis at a medical centre in Taiwan, 2005-10.
Topics: Adult; Aged; Aged, 80 and over; Aminosalicylic Acid; Antitubercular Agents; Drug Resistance, Bacterial; Ethambutol; Ethionamide; Female; Fluoroquinolones; Humans; Isoniazid; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Rifabutin; Rifampin; Streptomycin; Taiwan; Tuberculosis, Multidrug-Resistant | 2011 |
Clustering of Mycobacterium tuberculosis strains from foreign-born patients in Korea.
Topics: Antitubercular Agents; Cluster Analysis; DNA Transposable Elements; Emigrants and Immigrants; Female; Genotype; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Molecular Epidemiology; Mycobacterium tuberculosis; Ofloxacin; Republic of Korea; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2011 |
Rapid detection of isoniazid, rifampin, and ofloxacin resistance in Mycobacterium tuberculosis clinical isolates using high-resolution melting analysis.
Topics: Antitubercular Agents; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Isoniazid; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Mycobacterium tuberculosis; Ofloxacin; Polymerase Chain Reaction; Rifampin; Sensitivity and Specificity; Transition Temperature; Tuberculosis, Multidrug-Resistant | 2011 |
[Scrofuloderma with hypersensitivity to rifampicin and pyrazinamide, treated with a combination therapy including ofloxacin].
Topics: Adult; Antibiotics, Antitubercular; Diagnosis, Differential; Drug Eruptions; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Isoniazid; Ofloxacin; Pyrazinamide; Rifampin; Streptomycin; Tuberculosis, Cutaneous | 2012 |
Clinical, bacteriological and histopathological study of 62 referral relapse cases between Jan 2004 and Dec 2009 at the Foundation for Medical Research, Mumbai.
Topics: Academies and Institutes; Adult; Aged; Biomedical Research; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; India; Leprostatic Agents; Leprosy; Male; Middle Aged; Minocycline; Ofloxacin; Recurrence; Referral and Consultation; Rifampin; Risk Factors; Skin; Time Factors; Treatment Outcome; Young Adult | 2011 |
Effective antibiotics in combination against extreme drug-resistant Pseudomonas aeruginosa with decreased susceptibility to polymyxin B.
Topics: Amikacin; Anti-Bacterial Agents; beta-Lactamases; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Ofloxacin; Phylogeny; Polymyxin B; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Thienamycins; Time Factors | 2011 |
Buruli ulcer accompanied by pain in a Japanese patient.
Topics: Anti-Bacterial Agents; Asian People; Buruli Ulcer; Clarithromycin; Drug Therapy, Combination; Face; Female; Humans; Middle Aged; Mycobacterium ulcerans; Ofloxacin; Pain; Rifampin | 2012 |
Integrated detection of multi- and extensively drug-resistant tuberculosis using the nitrate reductase assay.
Topics: Antitubercular Agents; Colorimetry; DNA Mutational Analysis; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Humans; Isoniazid; Kanamycin; Kanamycin Resistance; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Nitrate Reductase; Ofloxacin; Predictive Value of Tests; Rifampin; Sensitivity and Specificity; Time Factors; Tuberculosis, Multidrug-Resistant | 2012 |
φ(2)GFP10, a high-intensity fluorophage, enables detection and rapid drug susceptibility testing of Mycobacterium tuberculosis directly from sputum samples.
Topics: Antitubercular Agents; Bacteriophages; Genes, Reporter; Genetic Vectors; Green Fluorescent Proteins; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Promoter Regions, Genetic; Recombinant Proteins; Rifampin; Signal-To-Noise Ratio; Sputum; Tuberculosis, Pulmonary | 2012 |
Synergistic effect of two combinations of antituberculous drugs against Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Bacterial; Drug Synergism; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin | 2012 |
Extra-pulmonary primary multidrug-resistant tubercular lymphadenitis in an HIV negative patient.
Topics: Adult; Antitubercular Agents; Clarithromycin; Clofazimine; Cycloserine; Diagnosis, Differential; Drug Therapy, Combination; Ethambutol; Ethionamide; Female; HIV Seronegativity; Humans; Isoniazid; Kanamycin; Ofloxacin; Pyrazinamide; Rifampin; Tuberculosis, Lymph Node; Tuberculosis, Multidrug-Resistant | 2012 |
Evaluation of antimicrobial activity of certain combinations of antibiotics against in vitro Staphylococcus epidermidis biofilms.
Topics: Biofilms; Clindamycin; Drug Combinations; Gentamicins; Humans; Levofloxacin; Microbial Sensitivity Tests; Ofloxacin; Rifampin; Staphylococcal Infections; Staphylococcus epidermidis | 2012 |
Multilayer, degradable coating as a carrier for the sustained release of antibiotics: preparation and antimicrobial efficacy in vitro.
Topics: Animals; Anti-Bacterial Agents; Cell Line; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Gram-Negative Bacteria; Gram-Positive Bacteria; Mice; Ofloxacin; Polyesters; Polypropylenes; Rifampin | 2012 |
Pharmacokinetic and dynamic study of levofloxacin and rifampicin in bone and joint infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Area Under Curve; Arthritis, Infectious; Body Mass Index; Discitis; Dose-Response Relationship, Drug; Female; Fracture Fixation, Internal; Gastrointestinal Diseases; Humans; Levofloxacin; Male; Middle Aged; Musculoskeletal Diseases; Ofloxacin; Osteitis; Prospective Studies; Prosthesis-Related Infections; Rifampin; Sacroiliitis; Staphylococcal Infections; Surgical Wound Infection | 2012 |
Persister eradication: lessons from the world of natural products.
Topics: Anti-Bacterial Agents; Biofilms; Biological Products; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Microbial Viability; Mycobacterium tuberculosis; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections; Rifampin; Species Specificity; Time Factors; Tuberculosis | 2012 |
Genotype MTBDRsl line probe assay shortens time to diagnosis of extensively drug-resistant tuberculosis in a high-throughput diagnostic laboratory.
Topics: Amikacin; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Extensively Drug-Resistant Tuberculosis; Genetic Markers; Genotype; Humans; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Mycobacterium tuberculosis; Ofloxacin; Pentosyltransferases; Rifampin; Sensitivity and Specificity; South Africa; Sputum; Time Factors | 2012 |
Study of the rifampin monoresistance mechanism in Mycobacterium tuberculosis.
Topics: Antitubercular Agents; Bacterial Proteins; Base Sequence; Biological Transport; DNA-Directed RNA Polymerases; Drug Resistance, Bacterial; Escherichia coli; Ethambutol; Genotype; Isoniazid; Kanamycin; Membrane Transport Proteins; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Protein Structure, Secondary; Protein Structure, Tertiary; Rifampin; Sequence Analysis, DNA; Streptomycin; Tuberculosis | 2013 |
[Miliary X-ray pattern is not always related to tuberculosis].
Topics: Aged; Anti-Bacterial Agents; Arthroplasty, Replacement, Hip; Combined Modality Therapy; Device Removal; Diagnosis, Differential; Drug Therapy, Combination; Dyspnea; Femoral Neck Fractures; Hip Prosthesis; Humans; Male; Ofloxacin; Pneumonia, Staphylococcal; Prosthesis-Related Infections; Rifampin; Staphylococcal Infections; Tomography, X-Ray Computed; Tuberculosis, Miliary | 2013 |
Relationship and susceptibility profile of Staphylococcus aureus infection diabetic foot ulcers with Staphylococcus aureus nasal carriage.
Topics: Adult; Aged; Anti-Bacterial Agents; Carrier State; Diabetic Foot; Female; Humans; Levofloxacin; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Nose; Ofloxacin; Rifampin; Risk Factors; Staphylococcal Infections | 2013 |
Histoid leprosy: case report.
Topics: Aged; Atrophy; Dermis; Epidermis; Humans; Leprostatic Agents; Leprosy; Male; Minocycline; Ofloxacin; Rifampin | 2012 |
Inadequate therapeutic response to a recommended antituberculosis fixed-dose combination regimen in an overweight patient with Mycobacterium bovis infection.
Topics: Adult; Antitubercular Agents; Drug Combinations; Drug Monitoring; Drug Therapy, Combination; Humans; Isoniazid; Levofloxacin; Male; Mycobacterium bovis; Ofloxacin; Overweight; Practice Guidelines as Topic; Pyrazinamide; Rifampin; Treatment Outcome; Tuberculosis, Lymph Node | 2013 |
Developing new MDT regimens for MB patients; time to test ROM 12 month regimens globally.
Topics: Clofazimine; Dapsone; Drug Administration Schedule; Drug Therapy, Combination; Humans; Leprostatic Agents; Leprosy; Minocycline; Mycobacterium leprae; Ofloxacin; Patient Compliance; Rifampin; World Health Organization | 2012 |
Incidence and risk factors for extensively drug-resistant tuberculosis in Delhi region.
Topics: Adult; Amikacin; Antitubercular Agents; Capreomycin; Ethionamide; Extensively Drug-Resistant Tuberculosis; Female; Humans; Incidence; India; Isoniazid; Male; Mycobacterium tuberculosis; Ofloxacin; Prevalence; Rifampin; Risk Factors; Sputum; Tuberculosis, Pulmonary | 2013 |
[Bifocal Buruli ulcer: multiple cephalic lesions after initiation of medical treatment].
Topics: Anti-Bacterial Agents; Buruli Ulcer; Child, Preschool; Chin; Cicatrix; Cote d'Ivoire; Drug Therapy, Combination; Endemic Diseases; Facial Dermatoses; Female; Humans; Leg; Levofloxacin; Mycobacterium ulcerans; Ofloxacin; Rifampin; Scalp Dermatoses; Time Factors | 2013 |
Characterization of mutations in multi- and extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea.
Topics: Acetyltransferases; Amidohydrolases; Amikacin; Antigens, Bacterial; Bacterial Proteins; Capreomycin; Catalase; DNA Gyrase; DNA Primers; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Fluoroquinolones; Genetic Loci; Humans; Isoniazid; Kanamycin; Mutation; Mycobacterium tuberculosis; Ofloxacin; Oxidoreductases; Pentosyltransferases; Polymerase Chain Reaction; Promoter Regions, Genetic; Pyrazinamide; Republic of Korea; Rifampin; Sequence Analysis, DNA; Streptomycin; Tuberculosis, Multidrug-Resistant | 2013 |
[Clinical evaluation of a line probe assay kit for the identification of Mycobacterium species and detection of drug-resistant Mycobacterium tuberculosis].
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Humans; Isoniazid; Levofloxacin; Microbial Sensitivity Tests; Mutation; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Rifampin | 2013 |
Estimation of content of anti-TB drugs supplied at centres of the Revised National TB Control Programme in Tamil Nadu, India.
Topics: Antitubercular Agents; Cycloserine; Drug Stability; Drug Storage; Drug Therapy, Combination; Ethambutol; Ethionamide; Humans; India; Isoniazid; Levofloxacin; Ofloxacin; Pyrazinamide; Rifampin; Spectrophotometry; Tuberculosis | 2013 |
Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from China.
Topics: Antitubercular Agents; Bacterial Proteins; Capreomycin; Genotype; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis, Multidrug-Resistant | 2014 |
[Spondylodiscitis and Lactococcus cremoris endocarditis].
Topics: Aged; Animals; Anti-Bacterial Agents; Bacteremia; Braces; Cattle; Combined Modality Therapy; Discitis; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Food Contamination; Gentamicins; Gram-Positive Bacterial Infections; Humans; Lactococcus; Lumbar Vertebrae; Milk; Ofloxacin; Pasteurization; Rifampin | 2013 |
Evaluation of indirect drug susceptibility testing using the MODS assay for the detection of XDR-TB in China.
Topics: Antitubercular Agents; Bacteriological Techniques; China; DNA Mutational Analysis; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Feasibility Studies; Humans; Kanamycin; Microbial Sensitivity Tests; Microscopy; Mutation; Mycobacterium tuberculosis; Ofloxacin; Patient Selection; Predictive Value of Tests; Rifampin; Time Factors | 2014 |
Is drug-resistant Mycobacterium leprae a real cause for concern?: First approach to molecular monitoring of multibacillary Colombian patients with and without previous leprosy treatment.
Topics: Adolescent; Adult; Bacterial Proteins; Biopsy; Child; Colombia; Dapsone; DNA, Bacterial; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Genotype; Humans; Leprostatic Agents; Leprosy, Multibacillary; Male; Middle Aged; Mycobacterium leprae; Ofloxacin; Polymerase Chain Reaction; Retrospective Studies; Rifampin; Young Adult | 2014 |
Characterization of extensively drug-resistant Mycobacterium tuberculosis isolates circulating in Siberia.
Topics: Adult; Amikacin; Antitubercular Agents; Capreomycin; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Female; Genotype; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Minisatellite Repeats; Mutation; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Siberia; Tuberculosis; Young Adult | 2014 |
Performance of REBA MTB-XDR to detect extensively drug-resistant tuberculosis in an intermediate-burden country.
Topics: Adult; Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Female; Genes, MDR; Humans; Isoniazid; Kanamycin; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Predictive Value of Tests; Republic of Korea; Rifampin; Sputum; Streptomycin | 2015 |
Drug resistance in Mycobacterium leprae from patients with leprosy in China.
Topics: Adult; Bacterial Proteins; China; Dapsone; DNA, Bacterial; Drug Resistance, Bacterial; Female; Humans; Leprostatic Agents; Leprosy; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium leprae; Ofloxacin; Polymerase Chain Reaction; Prevalence; Rifampin | 2015 |
Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates.
Topics: Adult; Aged; Amikacin; Antitubercular Agents; Base Sequence; Capreomycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Ethionamide; Female; Humans; Isoniazid; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium tuberculosis; Ofloxacin; Oxidoreductases; Rifampin; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant | 2016 |
Confinement-Induced Drug-Tolerance in Mycobacteria Mediated by an Efflux Mechanism.
Topics: Antitubercular Agents; Bacterial Load; Biological Transport; Cinnamates; Diffusion; Dimethylpolysiloxanes; Drug Tolerance; Epigenesis, Genetic; Humans; Hygromycin B; Isoniazid; Lab-On-A-Chip Devices; Macrophages; Microdialysis; Models, Biological; Mycobacterium smegmatis; Mycobacterium tuberculosis; Ofloxacin; Phenotype; Rifampin | 2015 |
Prevalence of mutations conferring resistance among multi- and extensively drug-resistant Mycobacterium tuberculosis isolates in China.
Topics: Antitubercular Agents; Bacterial Proteins; Catalase; China; DNA-Directed RNA Polymerases; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Genes, Bacterial; Genetic Loci; Humans; Isoniazid; Mycobacterium tuberculosis; Ofloxacin; Oxidoreductases; Rifampin; Sequence Analysis, DNA | 2016 |
The thin-layer agar method for direct phenotypic detection of multi- and extensively drug-resistant tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Sensitivity and Specificity; Sputum | 2015 |
Evaluation of the direct nitrate reductase assay for rapid detection of extensively drug-resistant tuberculosis.
Topics: Adult; Capreomycin; China; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Nitrate Reductase; Ofloxacin; Prospective Studies; Rifampin; Sensitivity and Specificity; Sputum | 2016 |
Sensititre® MYCOTB MIC plate for drug susceptibility testing of Mycobacterium tuberculosis complex isolates.
Topics: Amikacin; Aminosalicylic Acid; Antitubercular Agents; China; Cycloserine; Ethambutol; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis | 2016 |
Rapid diagnosis of MDR and XDR tuberculosis with the MeltPro TB assay in China.
Topics: Amikacin; China; Extensively Drug-Resistant Tuberculosis; Humans; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Sensitivity and Specificity; Sputum; Tuberculosis, Multidrug-Resistant | 2016 |
A study on pre-XDR & XDR tuberculosis & their prevalent genotypes in clinical isolates of Mycobacterium tuberculosis in north India.
Topics: Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tuberculosis; Genotype; Humans; India; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Tuberculosis, Multidrug-Resistant | 2016 |
Leprosy Drug Resistance Surveillance in Colombia: The Experience of a Sentinel Country.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Proteins; Child; Colombia; Dapsone; DNA, Bacterial; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Female; Humans; Leprostatic Agents; Leprosy; Male; Microbial Sensitivity Tests; Middle Aged; Mutation; Mycobacterium leprae; Ofloxacin; Polymerase Chain Reaction; Recurrence; Rifampin; Sentinel Surveillance; Skin; Young Adult | 2016 |
qPCR-High resolution melt analysis for drug susceptibility testing of Mycobacterium leprae directly from clinical specimens of leprosy patients.
Topics: Bacterial Proteins; Dapsone; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Leprostatic Agents; Leprosy; Microbial Sensitivity Tests; Mycobacterium leprae; Ofloxacin; Real-Time Polymerase Chain Reaction; Reproducibility of Results; Rifampin; Sensitivity and Specificity; Sequence Analysis, DNA; Skin | 2017 |
Oral ofloxacin and clindamycin as an alternative to the classic rifampicin-clindamycin in hidradenitis suppurativa: retrospective analysis of 65 patients.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Child; Clindamycin; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Substitution; Drug Therapy, Combination; Female; Hidradenitis Suppurativa; Humans; Male; Middle Aged; Ofloxacin; Retrospective Studies; Rifampin; Treatment Outcome; Young Adult | 2018 |
Treatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China.
Topics: Adult; Antitubercular Agents; China; Cohort Studies; Extensively Drug-Resistant Tuberculosis; Female; Fluoroquinolones; Humans; Isoniazid; Lost to Follow-Up; Male; Middle Aged; Ofloxacin; Retrospective Studies; Rifampin; Treatment Failure; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2017 |
PknB remains an essential and a conserved target for drug development in susceptible and MDR strains of M. Tuberculosis.
Topics: Antitubercular Agents; Base Sequence; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Genetic Variation; Humans; India; Isoniazid; Microbial Sensitivity Tests; Mitoxantrone; Molecular Docking Simulation; Mutation; Mycobacterium tuberculosis; Ofloxacin; Phenotype; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Rifampin; Sequence Analysis; Streptomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2017 |
Machine learning for classifying tuberculosis drug-resistance from DNA sequencing data.
Topics: Antitubercular Agents; Ciprofloxacin; Ethambutol; Humans; Isoniazid; Machine Learning; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Pyrazinamide; Rifampin; Sequence Analysis, DNA; Streptomycin; Tuberculosis, Multidrug-Resistant | 2018 |
Leprosy in Nonimmigrant Canadian Man without Travel outside North America, 2014.
Topics: Aged; Anti-Bacterial Agents; Canada; Dapsone; Drug Therapy, Combination; Florida; Humans; Leprostatic Agents; Leprosy; Male; Mycobacterium leprae; Ofloxacin; Rifampin; Travel | 2018 |
Comparison of line probe assay to BACTEC MGIT 960 system for susceptibility testing of first and second-line anti-tuberculosis drugs in a referral laboratory in South Africa.
Topics: Antitubercular Agents; DNA, Bacterial; Ethambutol; Female; Genotype; Humans; Isoniazid; Kanamycin; Laboratories; Male; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Ofloxacin; Referral and Consultation; Rifampin; South Africa | 2017 |
Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009-15.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Biopsy, Needle; Brazil; Colombia; Dapsone; DNA Gyrase; Drug Resistance, Bacterial; Endemic Diseases; Epidemiological Monitoring; Global Health; Humans; India; Leprosy; Microbial Sensitivity Tests; Mutation; Mycobacterium leprae; Ofloxacin; Polymerase Chain Reaction; Prospective Studies; Recurrence; Rifampin; Sentinel Surveillance; Skin; Surveys and Questionnaires; World Health Organization | 2018 |
Use of whole-genome sequencing to predict Mycobacterium tuberculosis drug resistance in Shanghai, China.
Topics: Adult; Amikacin; Antitubercular Agents; China; Drug Resistance, Bacterial; Ethambutol; Humans; Isoniazid; Male; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Streptomycin; Tuberculosis; Whole Genome Sequencing | 2020 |
Sequence-based detection of first-line and second-line drugs resistance-associated mutations in Mycobacterium tuberculosis isolates in Isfahan, Iran.
Topics: Adult; Aged; Aged, 80 and over; Amikacin; Antitubercular Agents; Capreomycin; DNA Mutational Analysis; Drug Resistance, Multiple, Bacterial; Ethambutol; Female; Genetic Variation; Genotype; Humans; Iran; Isoniazid; Kanamycin; Male; Middle Aged; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Sequence Analysis, DNA; Tuberculosis, Multidrug-Resistant | 2020 |
Analysis of bacteriological Index between fixed multidrug therapy and new WHO recommended alternative regimen with ofloxacin, minocycline and clofazimine of rifampicin resistant cases from the hospitals of The Leprosy Mission, India.
Topics: Clofazimine; Drug Therapy, Combination; Hospitals; Humans; India; Leprostatic Agents; Leprosy; Minocycline; Ofloxacin; Rifampin; World Health Organization | 2020 |
Drug resistance gene mutations and treatment outcomes in MDR-TB: A prospective study in Eastern China.
Topics: Acetyltransferases; Adult; Amidohydrolases; Antitubercular Agents; Bacterial Proteins; Catalase; China; DNA Gyrase; DNA-Directed RNA Polymerases; Drug Resistance, Multiple, Bacterial; Female; Humans; Isoniazid; Kanamycin; Male; Middle Aged; Multivariate Analysis; Mutation; Mutation Rate; Mycobacterium tuberculosis; Odds Ratio; Ofloxacin; Prospective Studies; Rifampin; Sequence Analysis, DNA; Treatment Outcome; Tuberculosis, Multidrug-Resistant | 2021 |
After all, still a magnificent impersonator.
Topics: Adult; Biopsy; Clofazimine; Diagnostic Errors; Female; Humans; Leprostatic Agents; Mycobacterium; Mycobacterium Infections, Nontuberculous; Ofloxacin; Peripheral Nervous System Diseases; Rifampin; Skin; Vasculitis | 2021 |
Use of Whole-Genome Sequencing to Predict
Topics: Amikacin; Aminosalicylic Acid; Antitubercular Agents; China; Cycloserine; Drug Resistance; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Rifampin; Streptomycin; Tuberculosis, Multidrug-Resistant | 2022 |
Prediction of Mycobacterium tuberculosis drug resistance by nucleotide MALDI-TOF-MS.
Topics: Amikacin; Antitubercular Agents; China; Drug Resistance; Ethambutol; Humans; Isoniazid; Kanamycin; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Nucleotides; Ofloxacin; Rifampin; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Streptomycin; Tuberculosis, Lymph Node | 2022 |
Ofloxacin resistance in multibacillary new leprosy cases from Purulia, West Bengal: a threat to effective secondary line treatment for rifampicin-resistant leprosy cases.
Topics: Animals; Dapsone; Drug Resistance, Bacterial; Leprostatic Agents; Leprosy; Mice; Mycobacterium leprae; Ofloxacin; Rifampin | 2022 |
Promising Antimicrobial Activity and Synergy of Bacteriocins Against
Topics: Antitubercular Agents; Bacteriocins; Drug Synergism; Microbial Sensitivity Tests; Moxifloxacin; Mycobacterium tuberculosis; Ofloxacin; Rifampin | 2023 |
Prevalence of S. aureus and/or MRSA from seafood products from Indian seafood products.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Cefoxitin; Gentamicins; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Multilocus Sequence Typing; Ofloxacin; Piperacillin; Prevalence; Rifampin; Seafood; Serine; Staphylococcal Infections; Staphylococcus aureus; Sulbactam; Tazobactam; Trimethoprim, Sulfamethoxazole Drug Combination; Virulence Factors | 2022 |
A prospective case control study of resistance to rifampicin, dapsone and ofloxacin in Type 1 and Type 2 leprosy reactions and the therapeutic impact of modified treatment regimen on reactions.
Topics: Case-Control Studies; Dapsone; Drug Therapy, Combination; Humans; Hypersensitivity; Leprostatic Agents; Leprosy; Ofloxacin; Rifampin | 2023 |
High frequency of ofloxacin resistance patterns of Mycobacterium leprae from India: An indication to revisit second line anti-leprosy treatment regimen.
Topics: Cross-Sectional Studies; Dapsone; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; India; Leprostatic Agents; Leprosy; Mycobacterium leprae; Ofloxacin; Rifampin | 2023 |